Curriculum Vitae

PERSONAL DETAILS
ADMINISTRATIVE DUTIES
(Role),(Level),(Duration)
  • Research Training Unit Committee Member, Faculty, 01/01/2021 to present
  • Examiner for OSCE 1 Paper for "Required Summative Assessment", University Malaya, 03/02/2021 to 03/02/2021
  • Thesis Examiner for Master's Degree of Internal Medicine Examination , University Malaya, 17/11/2020 to 17/11/2020
  • Thesis Examiner for Master's Degree of Internal Medicine Examination , University Malaya, 17/11/2020 to 17/11/2020
  • Thesis Examiner for Master's Degree of Internal Medicine Examination, University Malaya, 17/11/2020 to 17/11/2020
  • Examiner OSCE Paper , University Malaya, 02/09/2020 to 02/09/2020
  • Assessor for Candidature Defence (Chairperson), University Malaya, 14/07/2020 to 14/07/2020
  • Assessor for Thesis Seminar, University Malaya, 25/06/2020 to 25/06/2020
  • Panel for Thesis Proposal Presentation, University Malaya, 23/06/2020 to 23/06/2020
  • Examiner for Clinical Examination, University Malaya, 10/03/2020 to 10/03/2020
  • Assessor for Candidature Defence (Chairperson), University Malaya, 25/02/2020 to 25/02/2020
  • SUPERVISOR, University Malaya, 25/02/2020 to 25/02/2020
  • Assessor for Thesis Seminar (Chairperson), University Malaya, 05/02/2020 to 05/02/2020
  • A member of the taskforce to update the 2015 CPG for management of T2DM , National, 18/01/2020 to 11/03/2020
  • Trainer for Gastroenterology Training Programme in Malaysia , National, 23/11/2017 to 23/11/2020
  • Thesis Examiner for Master's Degree Examination of Internal Medicine , University Malaya, 18/11/2019 to 18/11/2019
  • Thesis Examiner for Master's Degree Examination of Internal Medicine , University Malaya, 18/11/2019 to 18/11/2019
  • Thesis Examiner for Master's Degree Examination of Internal Medicine , University Malaya, 18/11/2019 to 18/11/2019
  • Thesis Examiner for Master's Degree Examination of Internal Medicine , University Malaya, 18/11/2019 to 18/11/2019
  • Thesis Examiner for Master's Degree Examination of Internal Medicine, University Malaya, 18/11/2019 to 18/11/2019
  • Thesis Examiner for Master's Degree Examination of Internal Medicine , University Malaya, 18/11/2019 to 18/11/2019
  • Assessor for Master in Medical Sciences Proposal Defence , University Malaya, 16/10/2019 to 16/10/2019
  • Assessor for Proposal Defence (Chairperson), University Malaya, 12/09/2019 to 12/09/2019
  • Assessor for Proposal Defence, University Malaya, 12/09/2019 to 12/09/2019
  • Assessor for Proposal Defence (Chairperson), University Malaya, 12/09/2019 to 12/09/2019
  • Assesor for Fundamental Research Grant Scheme (FRGS) , National, 08/07/2019 to 08/07/2019
  • OSCE Paper Examiner for Level 2 Professional Examinations, Session 2017/2018, University Malaya, 08/08/2018 to 08/08/2018
  • Examiner for UM Clinical Examination 2017 - Masters in Internal Medicine Examination, University Malaya, 08/05/2017 to 12/05/2017
  • Thesis Examiner for a master's degree of internal medicine examination, University Malaya, 21/11/2016 to 21/11/2016
  • Thesis Examiner for a master's degree of internal medicine examination, University Malaya, 21/11/2016 to 21/11/2016
  • Thesis Examiner for a master's degree of internal medicine examination, University Malaya, 21/11/2016 to 21/11/2016
  • Thesis Examiner for a master's degree of internal medicine examination, University Malaya, 21/11/2016 to 21/11/2016
  • Thesis Examiner for a master's degree of internal medicine examination, University Malaya, 21/11/2016 to 21/11/2016
  • Thesis Examiner for a master's degree of internal medicine examination, University Malaya, 21/11/2016 to 21/11/2016
  • COORDINATOR, Faculty, 20/06/2016 to 29/06/2016
  • Examiner for UITM Clinical Examination Part II Session May 2016 (Masters in Internal Medicine Programme), National, 17/05/2016 to 17/05/2016
  • PROGRAMME COORDINATOR, International, 08/04/2016 to 10/04/2016
  • 'Candidature Defence' Evaluation Seminar for Master candidate Lee Hooi leng, Faculty, 28/03/2016 to 29/03/2016
  • High Degree committee members of medical department, Faculty, 14/03/2016 to 14/03/2016
  • Project Coordinator for the 4th Edition of Accreditation Project under the Standard Malaysian Society for Quality in Health (MSQH) , Faculty, 07/11/2013 to 31/12/2013
  • Coordinator for University of Malaya Medical Program for Phase 1 and 2, Faculty, 09/09/2013 to present
  • QUALITY MANAGER, Faculty, 01/12/2010 to 31/12/2013
  • Assistant Coordinator for 3rd MBBS (Additional) Clinical Examination, Faculty, 24/10/2011 to 31/10/2011
  • Assistant Coordinator for 3rd MBBS Clinical Examination, Faculty, 08/08/2011 to 26/08/2011
ACADEMIC QUALIFICATION
(Qualification),(Field),(Institution),(Year)
  • PhD, MEDICINE, UNIVERSITI MALAYA (UM)
  • MRCP (UK), LAIN-LAIN, ROYAL COLLEGE OF PHYSICIANS, UNITED KINGDOM
  • MBBS, PERUBATAN DAN PEMBEDAHAN, UNIVERSITI MALAYA (UM)
MEMBERSHIPS
(Organisation),(Role),(Duration),(Level)
  • Associate Editor, Associate Editor, 2021 to present (International)
  • International Editorial Board Member, Editorial Board, 2020 to 2022 (International)
  • Member, Member, 2019 to present (International)
  • Scientific Co-Chair for Hepatology for Virtual Asian Pacific Digestive Week 2021, Committee Member, 2021 to 2021 (International)
  • Organizing Committee Member for Virtual Asian Pacific Digestive Week 2021, Committee Member, 2021 to 2021 (International)
  • Associate Editor, Associate Editor, 2018 to 2020 (International)
  • Asia Pacific Digestive Week 2020, Others, 2018 to 2020 (International)
  • Journal of Gastroenterology and Hepatology, Others, 2018 to 2020 (International)
  • The Asia Pacific Working Party on Non-Alcoholic Fatty Liver Disease, Member, 2016 to 2020 (International)
  • Gut and Obesity Asia, Member, 2014 to 2020 (International)
  • Prevention, surveillance and management of non-communicable diseases in primary and secondary health-care settings for the low and middle income countries, Others, 2018 to 2019 (International)
  • Journal of Clinical Imaging Science, Reviewer, 2017 to 2017 (International)
  • Journal of Clinical Imaging Science, Reviewer, 2016 to 2016 (International)
SPECIALIZATION
(Area)
Area of Expertise
  • GASTROENTEROLOGY (Diagnostic and Therapeutic Endoscopy, Viral Hepatitis B and C, Hepatocellular Carcinoma, Non-Alcoholic Fatty Liver Disease)
  • PUBLICATIONS
    (Title of publication in APA style)
    WoS
    2021
    • Ting, Y. W., Kong, A. S. Y., Zain, S. M., Chan, W. K., Tan, H. L., Mohamed, Z., . . . Mohamed, R. (2021). Loss-of-function HSD17B13 variants, non-alcoholic steatohepatitis and adverse liver outcomes: Results from a multi-ethnic Asian cohort. Clinical and Molecular Hepatology, 27(3), 486-498. doi: 10.3350/cmh.2020.0162
    • Ng, Y. Z., Lai, L. L., Wong, S. W., Mohamad, S. Y., Chuah, K. H., & Chan, W. K. (2021). Attenuation parameter and liver stiffness measurement using FibroTouch vs Fibroscan in patients with chronic liver disease. Plos One, 16(5), 13. doi: 10.1371/journal.pone.0250300
    • Tan, E. Z. Y., Lai, L. L., Vethakkan, S. R., Mustapha, N. R. N., Mahadeva, S., & Chan, W. K. (2021). Modest alcohol intake not associated with significant hepatic steatosis or more severe liver disease among patients with diabetes mellitus. Journal of Gastroenterology and Hepatology, 36(3), 751-757. doi: 10.1111/jgh.15160
    • Petroff, D., Blank, V., Newsome, P. N., Shalimar, Voican, C. S., Thiele, M., . . . Karlas, T. (2021). Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis. Lancet Gastroenterology & Hepatology, 6(3), 185-198. doi: 10.1016/s2468-1253(20)30357-5
    • Sang, C., Yan, H. M., Chan, W. K., Zhu, X. P., Sun, T., Chang, X. X., . . . Xie, G. X. (2021). Diagnosis of Fibrosis Using Blood Markers and Logistic Regression in Southeast Asian Patients With Non-alcoholic Fatty Liver Disease. Frontiers in Medicine, 8, 10. doi: 10.3389/fmed.2021.637652
    • Andrieux-Meyer, I., Tan, S. S., Thanprasertsuk, S., Salvadori, N., Menetrey, C., Simon, F., . . . Murad, S. (2021). Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial. Lancet Gastroenterology & Hepatology, 6(6), 448-458. doi: 10.1016/s2468-1253(21)00031-5
    • Wong, W. K., & Chan, W. K. (2021). Nonalcoholic Fatty Liver Disease: A Global Perspective. Clinical Therapeutics, 43(3), 473-499. doi: 10.1016/j.clinthera.2021.01.007
    • Zhou, Y. J., Gao, F., Liu, W. Y., Wong, G. L. H., Mahadeva, S., Mustapha, N. R. N., . . . Zheng, M. H. (2021). Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics, 54(4), 470-480. doi: 10.1111/apt.16487
    2020
    • Newsome, P. N., Sasso, M., Deeks, J. J., Paredes, A., Boursier, J., Chan, W. K., . . . Harrison, S. A. (2020). FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. Lancet Gastroenterology Hepatology, 5(4), 362-373. doi: 10.1016/s2468-1253(19)30383-8
    Scopus
    2021
    • Karuthan, S. R., Koh, P. S., Chinna, K., & Chan, W. K. (2021). Barcelona Clinic Liver Cancer and Hong Kong Liver Cancer staging systems for prediction of survival among Hepatocellular Carcinoma patients. The Medical journal of Malaysia, 76(2), 199-204.
    • Sang, C., Yan, H., Chan, W. K., Zhu, X., Sun, T., Chang, X., . . . Xie, G. (2021). Diagnosis of Fibrosis Using Blood Markers and Logistic Regression in Southeast Asian Patients With Non-alcoholic Fatty Liver Disease. Frontiers in Medicine, 8. doi: 10.3389/fmed.2021.637652
    Refereed Journals
    2021
    • M zes, F. E., Lee, J. A., Selvaraj, E. A., Jayaswal, A. N. A., Trauner, M., Boursier, J., ... & Pavlides, M. (2021). Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut. (WoS)
    • Ng YZ, Lai LL, Wong SW, Mohamad SY, Chuah KH, Chan WK. Attenuation parameter and liver stiffness measurement using FibroTouch vs Fibroscan in patients with chronic liver disease. PLoS One. 2021 May 3;16(5):e0250300. doi: 10.1371/journal.pone.0250300. PMID: 33939744; PMCID: PMC8092664. (WoS)
    • Karuthan SR, Koh PS, Chinna K, Chan WK. Barcelona Clinic Liver Cancer and Hong Kong Liver Cancer staging systems for prediction of survival among Hepatocellular Carcinoma patients. Med J Malaysia. 2021 Mar;76(2):199-204. PMID: 33742628. (SCOPUS)
    2020
    • Wong, S.W and Chan, W.K (2020). Epidemiology of non-alcoholic fatty liver disease in Asia Indian Journal of Gastroenterology. Indian Journal of Gastroenterology. (WoS)
    • Newsome, P. N., Sasso, M., Deeks, J.J., Paredes, A., Boursier, J., Chan, W-K et al. (2020). FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. Lancet Gastroenterol Hepatol. https://doi.org/10.1016/S2468-1253(19)30383-8 (WoS)
    • Eslam, M., Newsome, P. N., Anstee, Q. M., Targher, G., Gomez, M. R., Zelber-Segi, S et al. (2020). A new definition for metabolic associated fatty liver disease :an international expert consensus statement. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2020.03.039. (WoS)
    • Gao, F., Huang, J. F., Zheng, K. I., Pan, X. Y., Ma, H. L., Liu, W. Y et al. (2020). Development and validation of a novel non-invasive test for diagnosing fibrotic NASH in patients with biopsy-proven NAFLD. J Gastroenterol Hepatol. https://doi.org/10.1111/jgh.15055. (WoS)
    • Chan, T. T., Chan, W. K., Wong, G. L., Chan, A. W., Nik Mustapha, N. R., Chan, S. L (2020). Positive Hepatitis B core antibody is associated with cirrhosis and hepatocellular carcinoma in nonalcoholic fatty liver disease. Am J Gastroenterol. Doi: 10.14309/ajg.00(13)588. (WoS)
    • Wong, S. W., Chan, W. K., & Mohamed, R. (2020). Fatty liver is associated with advanced fibrosis but does not predict adverse outcomes in patients with chronic hepatitis B. Journal of viral hepatitis, 27(12), 1297-1305. (WoS)
    • Zain, S. M., Tan, H. L., Mohamed, Z., Chan, W. K., Mahadeva, S., Basu, R. C., & Mohamed, R. (2020). Use of simple scoring systems for a public health approach in the management of non alcoholic fatty liver disease patients. JGH Open, 4(6), 1155-1161. (WoS)
    • Chong CCN, Lakhtakia S, Nguyen N, et al. Endoscopic ultrasound-guided tissue acquisition with or without macroscopic on-site evaluation: randomized controlled trial [published online ahead of print, 2020 Jun 4]. Endoscopy. 2020;10.1055/a-1172-6027. doi:10.1055/a-1172-6027 (WoS)
    • Adams, L.A., and Chan, W.K. (2020). Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future. Semin Liv Dis. Doi: 10.1055/s-0040-1713006. (WoS)
    • Tan, E. Z-Y., Lai, L.L., Vethakkan, S. R., Nik Mustapha, N. R., Mahadeva, S., Chan, W-K . (in press). Modest alcohol intake is not associated with significant hepatic steatosis nor more severe liver disease in patient with diabetes mellitus. J Gastroen Hepatol. (WoS)
    • Yu, M. L., El Kassas Sr, M., Lam, B. P., Esmat, G., Femandez, M. C., Ferret, M. A. B., ... & Gordon, S. C. (2020). Patient-reported outcomes in patients with chronic Hepatitis C: data from The Global Liver Registry . [Abstract]. Hepatology, 72, 598A-599A. (WoS)
    • Pitisuttithum, P., Chan, W. K., Piyachaturawat, P., Imajo, K., Nakajima, A., Seki, Y et al. (2020). Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study. BMC Gastroenterology, 20, 1-9. Doi: 10.1186/s12876-020-01240-z. (WoS)
    • Yilmaz, Y., Yu, M. L., Lam, B. P., Ferret, M. A. B., Papatheodoridis, G., Chan Sr, W. K., ... & Isakov, V. A. (2020). The impact of chronic Hepatitis B on patient-reported outcomes from The Global Liver Registry . [Abstract]. Hepatology, 72, 471A-471A. (WoS)
    • Younossi, Z., Yilmaz, Y., El Kassas, M., Wong, V. W. S., Duseja, A. K., M ndez-Sanchez, N., ... & Alswat, K. (2020). Significant knowledge gap about non-alcoholic fatty liver disease (NAFLD) in real-world practices: a global survey of hepatologists, gastroenterologists, endocrinologists and primary care physicians. [Abstract]. Hepatology, 73, S440. (WoS)
    • Zhang, X., Goh, G. B. B., Chan, W. K., Wong, G. L. H., Fan, J. G., Seto, W. K., ... & Kim, S. U. (2020). Unhealthy lifestyle habits and physical inactivity among Asian patients with non alcoholic fatty liver disease. Liver International, 40(11), 2719-2731. (WoS)
    • Wong, G. L-H., Vincent Wong, W-S., Thompson, A., Jia, J., Hou, J., Lesmana, C.R.A., et al. (2020). Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement. Lancet Gastroenterol Hepatol. Doi.org/10.1016/S2468-1253(20)30190-4. (WoS)
    • Younossi, Z. M., Yilmaz, Y., Yu, M. L., Wong, V. W. S., Castellanos Fernandez, M., Isakov, V. A., ... & Bugianesi, E. (2020). Clinical and patient-reported outcomes data of non-alcoholic fatty liver disease: longitudinal data from the global NASH Registry [Abstract]. Hepatology, 72, 426A-427A. (WoS)
    • Chuah, K. H., Lai, L. L., Vethakkan, S. R., Nik Mustapha, N. R., Mahadeva, S., and Chan, W. K. ( 2020) Liver stiffness measurement in non alcoholic fatty liver disease: two is better than one. Journal of Gastroenterology and Hepatology, https://doi.org/10.1111/jgh.14978. (WoS)
    • Eslam, M., Sarin, S. K., Wong, V. W. S., Fan, J. G., Kawaguchi, T., Ahn, S. H., ... & Alam, S. (2020). The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatology International, 1-31. (WoS)
    • Tan, H. L., Zain, S. M., Eng, H. S., Mohamed, Z., Mahadeva, S., Chan, W. K., ... & Mohamed, R. (2020). Allele HLA DQB1* 06 reduces fibrosis score in patients with non alcoholic fatty liver disease. Hepatology Research, 50(8), 947-954. (WoS)
    2019
    • Wong VW, Irles M, Wong GL, Shili S, Chan AW, Merrouche W, Shu SS, Foucher J, Le Bail B, Chan WK, Chan HL, de Ledinghen V. Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease. Gut 2019, in press. (WoS)
    • Chuah, K., Chan, W. Quantification of Liver Fat in NAFLD: Available Modalities and Clinical Significance. Curr Hepatology Rep 18, 492 502 (2019) doi:10.1007/s11901-019-00493-x (Non-WoS/Non-SCOPUS)
    • Chan WK, Treeprasertsuk S, Goh GB, Fan JG, Song MJ, Charatcharoenwitthaya P, Duseja A, Dan YY, Imajo K, Nakajima A, Ho KY, Goh KL, Wong VW. Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients with Advanced Fibrosis. Clin Gastroenterol Hepatol 2019, in press. (WoS)
    • Chuah KH, Wan Yusoff WNI, Sthaneshwar P, Nik Mustapha NR, Mahadeva S, Chan WK. MACK-3 (Combination of hoMa, Ast, CK18): a promising novel biomarker for fibrotic non-alcoholic steatohepatitis. Liver Int 2019, in press. (WoS)
    • Kamarajah SK, Khoo S, Chan WK, Sthaneshwar P, Nik Mustapha NR, Mahadeva S. Limited applicability of cathepsin D for the diagnosis and monitoring of non-alcoholic steatohepatitis. JGH Open 2019, in press. (Non-WoS/Non-SCOPUS)
    • Chuah KH, Chan WK. Reply to: CHAI and MACK-3 as noninvasive indices for nonalcoholic steatohepatitis. Liver Int 2019, in press. (WoS)
    • Leong WL, Lai LL, Nik Mustapha NR, Vijayananthan A, Rahmat K, Mahadeva S, Chan WK. Comparing point shear wave elastography (ElastPQ) and transient elastography for diagnosis of fibrosis stage in nonalcoholic fatty liver disease. J Gastroenterol Hepatol 2019, in press (WoS)
    • Khoo S, Wong VW, Goh GB, Fan JG, Chan WK, Seto WK, Chow WC. Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol 2019, in press. (WoS)
    • Chan WK, Wong VW. A new bile acid treatment for non-alcoholic fatty liver disease. Lancet Gastroenterol Hepatol 2019, in press. (WoS)
    • Jayaraman, T., Lee, Y.Y., Chan, W.K., and Mahadeva, S. Epidemiological differences of common liver conditions between Asia and the West. Journal of Gastroenterology and Hepatology. (2019), doi: 10.1002/jgh3.12275. (WoS)
    • Harry, S., Lee, L. L., Nik Mustapha, N.R., Abdul Aziz, Y.F., Vijayananthan, A., Rahmat, K., Mahadeva, S., Chan, W.K. (in press). Volumetric liver fat fraction determines grade of steatosis more accurately than controlled attenuation parameter in patients with nonalcoholic fatty liver disease. Clinical Gastroenterology and Hepatology (2019). doi: https://doi.org/10.1016/j.cgh.2019.08.023. (WoS)
    • Lai LL, Vethakkan SR, Nik Mustapha NR, Mahadeva S, Chan WK. Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus. Dig Dis Sci 2019, in press. (WoS)
    • Fu, C., Wai, J.W., Nik Mustapha, N.R., Irles, M., Lai-Hung Wong, G., Mahadeva, S., Shili, S., Wing-Hung Chan, A., Merrouche, W., Lik-Yuen Chan, H., Foucher, J., Le Bail, B., Wai-Sun Wong, V., Chan, W.K., de L dinghen, V. Performance of simple fibrosis scores in non-obese patients with nonalcoholic fatty liver disease. Clinical Gastroenterology and Hepatology (2019), doi: https://doi.org/10.1016/j.cgh.2019.09.027. (WoS)
    2018
    • Chan WK, Treeprasertsuk S, Imajo K, Nakajima A, Seki Y, Kasama K, Kakizaki S, Fan JG, Song MJ, Yoon SK, Dan YY, Lesmana L, Ho KY, Goh KL, Wong VW. Clinical features and treatment of non-alcoholic fatty liver disease across the Asia Pacific region the GO ASIA initiative. Aliment Pharmacol Ther 2018, in press. (WoS)
    • Karlas T, Petroff D, Sasso M, Fan JG, Mi YQ, de L dinghen V, Kumar M, Lupsor-Platon M, Han KH, Cardoso AC, Ferraioli G, Chan WK, Wong VW, Myers RP, Chayama K, Friedrich-Rust M, Beaugrand M, Shen F, Hiriart JP, Sarin SK, Badea R, Lee HW, Marcellin P, Filice C, Mahadeva S, Wong GL, Crotty P, Masaki K, Bojunga J, Bedossa P, Keim V, Wiegand J. Impact of Controlled Attenuation Parameter on Detecting Fibrosis using Liver Stiffness Measurement. Aliment Pharmacol Ther 2018, in press. (WoS)
    • Chan WK, Dan YY, Wong VWS, for the GO ASIA Initiative. (2018). Editorial: NAFLD in Asia clinical associations with advanced disease become clearer Authors reply. Aliment Pharmacol Ther, in press. (WoS)
    • Lai, L.L., Wan Yusoff, W.N.I., Vethakkan, S.R., Nik Mustapha, N.R., Chan W.K., (2018).Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography. Journal of Gastroenterology and Hepatology. doi:10.1111/jgh.14577 (WoS)
    • Kamarajah, S.K., Chan, WK., Nik Mustapha, N.R. et al., (2018) Repeated liver stiffness measurement compared with paired liver biopsy in patients with non-alcoholic fatty liver disease. Hepatol Int. (WoS)
    • Tan, E. C., Tai, M. S., Chan, W., & Mahadeva, S. (2018). Association between non-alcoholic fatty liver disease evaluated by transient elastography with extracranial carotid atherosclerosis in a multiethnic Asian community. JGH Open, 1-9. doi:10.1002/jgh3.12114 (Non-WoS/Non-SCOPUS)
    • Chan WK, Yeoh KY, Lim CY, Lai SM, Lee JY, Leow AHR, Goh KL.(in press) Hepatitis B virus infection among children of hepatitis B surface antigen positive mothers in a Malaysian hospital. Med J Malaysia. (Non-WoS/Non-SCOPUS)
    • Khoo, S., Chan, W.K., & Mahadeva, S. (2018). Endoscopic management of colonoscopy-related perforation. Journal of Digestive Endoscopy, 9(20),47-52. (Non-WoS/Non-SCOPUS)
    • Wong SW, Ting YW, Chan WK. Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma and its implications. JGH Open 2018, 1-7. (Non-WoS/Non-SCOPUS)
    • Chan WK, Nik Mustapha NR, Mahadeva S, Wong VW, Cheng JY, Wong GL. Can the same controlled attenuation parameter cut-offs be used for M and XL probes for diagnosing hepatic steatosis? J Gastroenterol Hepatol 2018;33:1787-1795 (WoS)
    2017
    • Lee-Lee Lai, Wah-Kheong Chan, Pavai Sithaneshwar, Nik Raihan Nik Mustapha, Khean-Lee Goh & Sanjiv Mahadeva (2017) Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in non-alcoholic fatty liver disease. PLoS ONE 12(4): e0174982. (WoS)
    • Say-Yee Loo, Wah-Kheong Chan. Emerging new standard for non-invasive assessment of liver disease mortality in non-alcoholic fatty liver disease. Hepatobiliary Surg Nutr 2017. doi: 10.21037/hbsn.2017.03.06 (Non-WoS/Non-SCOPUS)
    • Karlas T, Petroff D, Sasso M, Fan JG, Mi YQ, de L dinghen V, Kumar M, Lupsor-Platon M, Han KH, Cardoso AC, Ferraioli G, Chan WK, Wai-Sun Wong V, Myers RP, Chayama K, Friedrich-Rust M, Beaugrand M, Shen F, Hiriart JB, Sarin SK, Badea R, Sik Jung K, Marcellin P, Filice C, Mahadeva S, Lai-Hung Wong G, Crotty P, Masaki K, Bojunga J, Bedossa P, Keim V, Wiegand J. Individual Patient Data Meta-Analysis of Controlled Attenuation Parameter (CAP) Technology for Assessing Steatosis. J Hepatol 2017, 66(5): 1022-1030. (WoS)
    • Wong VW, Chan WK, Chitturi S, Chawla Y, Dan YY, Duseja A, Fan J, Goh KL, Hamaguchi M, Hashimoto E, Kim SU, Lesmana LA, Lin YC, Liu CJ, Ni YH, Sollano J, Wong SK, Wong GL, Chan HL, Farrell G. The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 1: Definition, risk factors and assessment. J Gastroenterol Hepatol 2017, in press (WoS)
    • Chan WK, Nik Mustapha NR, Wong GL, Wong VW, Mahadeva S. Controlled attenuation parameter using Fibroscan XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population, UEG Journal 2017; 5(1): 76-85. (WoS)
    • Wah Kheong C, Nik Mustapha NR, Mahadeva S. A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2017;15(12):1940-9 e8. (WoS)
    • Wong VW, Chan WK, Chitturi S, Chawla Y, Dan YY, Duseja A, Fan J, Goh KL, Hamaguchi M, Hashimoto E, Kim SU, Lesmana LA, Lin YC, Liu CJ, Ni YH, Sollano J, Wong SK, Wong GL, Chan HL, Farrell G. The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 2: Management and special groups. J Gastroenterol Hepatol 2017, in press. (WoS)
    • Huiyan L, Chan WK, Neto MG. Endoscopic sleeve gastroplasty: case report, technique and literature review. J Dig Dis 2017, in press. (WoS)
    2016
    • Ahmad Najib Azmi, Wah-Kheong Chan, Sanjiv Mahadeva, Khean-Lee Goh. Split-dose low volume bowel preparation, a feasible option for preparation for colonoscopy. Endoscopy 2016; 48(2): 197. (WoS)
    • Chan WK, Wong VW. Oxidized low-density lipoprotein in non-alcoholic steatohepatitis. J Gastroenterol Hepatol 2016; 31(9): 1516-18. (WoS)
    • Jianyi Calvin Koh, Wai Mun Loo, Khean-Lee Goh, Kentaro Sugano, Wah-Kheong Chan, Wai-Yan Philip Chiu, Myung-Gyu Choi, Sutep Gonlachanvit, Wei-Jei Lee, Wei-Jie Jonathan Lee, Yeong Yeh Lee, Laurentius A Lesmana, You-Ming Li, Chun-Jen Liu, Bunzo Matsuura, Atsushi Nakajima, Enders Kwok Wai Ng, Jose D Sollano, Simon Kin-Hung Wong, Vincent Wai-Sun Wong, Yunsheng Yang, Khek-Yu Ho, Yock-Young Dan. Asian Consensus on the Relationship between Obesity and Gastrointestinal and Liver Diseases. J Gastroenterol Hepatol 2016; 31(8): 1405-13. (WoS)
    • Chee-Chiat Liong, Sarala Ravindran, Gnana Kumar Gnanasuntharam, Edmund Fui-Min Chin, Peng-Soon Koh, Wah-Kheong Chan. Enteropathy-associated T-cell lymphoma: an extremely rare cause of chronic diarrhoea. Med J Malaysia 2016; 71(2): 88-90. (SCOPUS)
    2015
    • Zain SM, Mohamed Z, Pirmohamed M, Tan HL, Alshawsh MA, Mahadeva S, Chan WK, Mustapha NR, Mohamed R. Copy number variation in exportin-4 (XPO4) gene and its association with histological severity of non- alcoholic fatty liver disease. Sci Rep. 2015; 5: 13306. (WoS)
    • Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. A novel 2-step approach combining the NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis. Hepatol Int. 2015; 9(4): 594-602. (WoS)
    • Wah-Kheong Chan, Alexander Tong-Boon Tan, Shireene Ratna Vethakkan, Pei-Chien Tah, Anushya Vijayananthan, Khean-Lee Goh. Low physical activity and energy dense Malaysian foods are associated with non-alcoholic fatty liver dis-ease in centrally obese but not in non-centrally obese patients with diabetes mellitus. Asia Pac J Clin Nutr. 2015; 24(2): 289-98. (WoS)
    • Ahmad Najib Azmi, Wah-Kheong Chan, Khean-Lee Goh. Sustained complete remission of advanced hepatocellular carcinoma with sorafenib therapy. J Dig Dis. 2015; 16(9): 537-40. (WoS)
    • Rajvinder Singh, Mahesh Jayanna, Jennie Wong, Lee Guan Lim, Jun Zhang, Jing Lv, Dong Liu, Yi-Chia Lee, Ming-Lun Han, Ping-Huei Tseng, Vikneswaran Namasivayam, Rupa Banerjee, Noriya Uedo,Wah Kheong Chan, Shiaw Hooi Ho, Shi-yao Chen, Shobna Bhatia, Kohei Funasaka, Takafumi Ando, Justin Wu, Cosmas Lesmana, William Tam, Wen-Lun Wang, Chi-Yang Chang, Hwoon-Yong Jung, Kee Wook Jung, Muhammad Begawan Bestari, Kenshi Yao, Vui Heng Chong, Prateek Sharma, Khek-Yu Ho. Narrow-band imaging and white- light endoscopy with optical magnification in the diagnosis of dysplasia in Barrett s esophagus: results of the Asia-Pacific Barrett s Consortium. Endoscopy International Open. 2015; 3(1): E14-8. (Non-WoS/Non-SCOPUS)
    2014
    • Zain SM, Rosmawati M, Cooper D, Razali R, Rampal S, Mahadeva S, Chan WK, Anwar A, Nurul SMR, Anis SF, Cheah PL, Basu RC, Tan HL, Mohamed Z. Genome-wide analysis of copy number variation identifies candidate gene loci associated with the progression of non- alcoholic fatty liver disease. PLOS ONE 2014;9 (4):e95604 , PLOS ONE 9(4):E95604 APRIL 2014. Impact Factor: 3.53. DOI: 10.1371/journal.pone.0095604 (WoS)
    • Wah-Kheong Chan, Alexander Tong-Boon Tan, Shireene Ratna Vethakkan, Pei-Chien Tah, Anushya Vijayananthan, Khean-Lee Goh. Ultrasonography- diagnosed non-alcoholic fatty liver disease is not associated with prevalent ischemic heart disease among diabetics in a multiracial Asian hospital clinic population. Clin Res Hepatol Gastroenterol. 2014; 38(3): 284-91. (WoS)
    • Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers. PLoS One. 2014; 9(9): e105903. (WoS)
    • Wah-Kheong Chan, Norhaniza Bahar, Hamizah Razlan, Anushya Vijayananthan, Pavai Sithaneshwar, Khean-Lee Goh. Non-alcoholic fatty liver disease in a young multiracial Asian population - a worrying ethnic predilection in Malay and Indian males. Hepatol Int. 2013; 8(1); 121-7. (WoS)
    • Chan W. K., Najib Azmi, Mahadeva S., Goh K. L. (2014). Split-dose vs same-day reduced-volume polyethylene glycol electrolyte lavage solution for morning colonoscopy. World J Gastroenterol. 2014; 20(39): 14488-94. (WoS)
    • Wah-Kheong Chan, Ida Normiha Hilmi, Phaik-Leng Cheah, Khean-Lee Goh. Progression of non-alcoholic fatty liver disease - a prospective clinicopathological follow-up study. J Dig Dis. 2014; 15(10): 545-52. (WoS)
    • Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Controlled attenuation parameter for detection and quantification of hepatic steatosis in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2014; 29(7): 1470-6. (WoS)
    2013
    • Wah-Kheong Chan, Alexander Tong-Boon Tan, Vethakkan Shireene Ratna, Pei-Chien Tah, Vijayananthan Anushya, Khean-Lee Goh. Non-Alcoholic Fatty Liver Disease (NAFLD) in Diabetics Prevalence and Predictive Factors in a Multi-Racial Hospital Clinic Population in Malaysia. J Gastroenterol Hepatol 2013, 28 (8): 1375 - 83. (WoS)
    • Chan WK, Roslani AC, Law CW, Goh KL, Mahadeva S. 2013. Clinical outcomes and direct costing of endoluminal clipping compared to surgery in the management of iatrogenic colonic perforation. J Dig Dis. 2013; 14(12):670-5. doi: 10.1111/1751-2980.12097 (WoS)
    • Wah-Kheong Chan, Khean-Lee Goh. Epidemiology of a Fast-Emerging Disease in the Asia Pacific Region - Non-Alcoholic Fatty Liver Disease (NAFLD). Hepatol Int. 2013; 7(1): 65-71. (WoS)
    2012
    • Wah-Kheong Chan, Jaganathan Vijayasangkar, Sanjiv Mahadeva. Cyclosporine Rescue Therapy in Autoimmune Liver Cirrhosis: A Case Report. Turkish Journal of Gastroenterology 2012. (WoS)
    • Wah-Kheong Chan, Khean-Lee Goh. Evaluation of Patient Satisfaction of an Outpatient Colonoscopy Service in an Asian Tertiary Care Hospital. Gastroenterology Research and Practice 2012. (WoS)
    • Khean-Lee Goh, Wah-Kheong Chan. Commentary: changing aetiology of peptic ulcers. Alimentary Pharmacology and Therapeutics 2012. (WoS)
    • Najib Azmi, Wah-Kheong Chan, Khean-Lee Goh. Evaluation of patient satisfaction of an outpatient gastroscopy service in an Asian tertiary care hospital. BMC Gastroenterology 2012, 12:96. (WoS)
    2011
    • Sanjiv Mahadeva, Wah-Kheong Chan, Mohammed Mohazmi, Ramanujam Sujarita, Khean-Lee Goh. A validation study of the Leeds Dyspepsia Questionnaire in a multi-ethnic Asian population. J Gastroenterol Hepatol. 2011 Jun 8. doi: 10.1111/j.1440-1746.2011.06806.x. [Epub ahead of print] (WoS)
    • Wah-Kheong Chan, Arjunan Saravanan, Jeeta Manikam, Khean-Lee Goh, Sanjiv Mahadeva. Appointment waiting times and education level influence the quality of bowel preparation in adult patients undergoing colonoscopy. BMC Gastroenterol 2011. Jul 28;11:86. (WoS)
    • Khean-Lee Goh, Wah-Kheong Chan, Seiji Shiota, Yoshio Yamaoka. 2011. Epidemiology of Helicobacter pylori Infection and Public Health Implications. Helicobacter 16: 1 9. (WoS)
    Article in Proceedings
    2021
    • Younossi, Z., Yilmaz, Y., El-Kassas, M., Duseja, A. K., Hamid, S. S., Esmat, G., ... & Stepanova, M. (2021, July). The Impact of COVID-19 Pandemic on Patients with Chronic Liver Disease (CLD): Data from the Global Registry. In Journal of Hepatology (Vol. 75, pp. S655-S655). RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS: ELSEVIER.
    • Younossi, Z., Harrison, S., Newsome, P. N., Chan, W. K., Yilmaz, Y., de Ledinghen, V., ... & Sanyal, A. (2021, July). Development and validation of Agile 3+: novel FibroScan based score for the diagnosis of advanced fibrosis in patients with nonalcoholic fatty liver disease. In JOURNAL OF HEPATOLOGY (Vol. 75, pp. S257-S257). RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS: ELSEVIER.
    • Zhou, Y. J., Gao, F., Liu, W. Y., Wong, G. L. H., Mahadeva, S., Raihan Nik Mustapha, N., ... & Zheng, M. H. (2021). Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics.
    • Mozes, F., Lee, J., Selvaraj, E., Jayaswal, A., Trauner, M., Boursier, J., ... & Pavlides, M. (2021, July). Individual patient data meta-analysis of the diagnostic performance of single and sequentially combined non-invasive tests in detecting advanced fibrosis. In JOURNAL OF HEPATOLOGY (Vol. 75, pp. S259-S260). RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS: ELSEVIER.
    • LS Zee, CK Huat, B Ruveena, K Stanley, S Shahreedhan, CW Kheong, HS Hooi, M Rosmawati, H Ida, GK Lee, M Sanjiv. The spectrum of gastrointestinal and liver diseases has an ethnic predilection: observations from a specialist clinic in Malaysia. Journal of Gastroenterology and Hepatology. 36 (Suppl. 2): 40
    • Wong WK, Lim SK, Ganapathy S, Chan WK. Metabolic-dysfunction-associated fatty liver disease (MAFLD) and advanced liver fibrosis among hemodialysis patients in a multiracial urban population in Malaysia. Journal of Gastroenterology and Hepatology. 36 (Suppl. 2): 49.
    • Tan SS, Mohd Said HRH, Abu Hassan MR, Omar H, Tee HP, Chan WK, Kumar S, Mustafa M, Md Salleh MF, Adnan SD, Thongsawat S, Thetket K, Avihingsanon A, Khemnark S, Salvadori N, Brachet L. Concordance between Fibroscan and aspartate aminotransferase-to-platelet ratio index (APRI) using different cut-off values in 603 Asian adults with chronic hepatitis C virus (HCV) with no or compensated cirrhosis in Thailand and Malaysia. Journal of Gastroenterology and Hepatology. 36 (Suppl. 2): 259.
    2020
    • Tan S.S., Mohd. Said R., Abu Hassan M.R., Omar H., Tee H.P., Chan W.K., et al. (2020, December 4-5). Concordance between FibroScan and Aspartate aminotransferase-to-Platelet Ratio Index (APRI) using different cut-off values in 301 Asian adults with chronic HCV with no or compensated cirrhosis in Thailand and Malaysia [Poster presentation]. International Viral Hepatitis Elimination Meeting (IVHEM) 2020. https://dndi.org/events/2020/international-viral-hepatitis-elimination-meeting-ivhem-2020/.
    2019
    • Khoo S, Wong VW, Goh GB, Fan JG, Chan WK, Seto WK, Chow WC. Prescription of statin and treatment targets in non-alcoholic fatty liver disease patients. Hepatol Int 2019; 13(Suppl 1): S196. (WoS)
    • Tan H.L., Shahrani S., Mohd. Zain S., Mohamed Z., Chan W.K., Mahadeva S., & Mohamed R. (2019). Non-Invasive Scoring Systems for the Diagnosis of Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease (NAFLD) in a Malaysian Cahort. Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology GUT2019. (Non-WoS/Non-SCOPUS)
    • Chuah K.H., Lai L.L., Vethakkan S.R.,Nik Mustapha N.R., Mahadeva S., & Chan W.K. (2019). Liver stiffness measurement in non-alcoholic fatty liver disease: two is better than one. Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology GUT2019. (Non-WoS/Non-SCOPUS)
    • Chuah K.H., Wan Yusoff W.N.I., Sthaneshwar P., Nik Mustaffa N.R., Mahadeva S., & Chan W.K. (2019). MACK-3 (Combination of HOMA, AST, CK18): A promising novel biomarker for fibrotic non-alcoholic steatohepatitis. Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology GUT2019. (Non-WoS/Non-SCOPUS)
    • Khoo S., Sun Wong V.W., Bee Goh G.B., Fan J., Chan W.K., Seto W.K., & Chow W.C. (2019). Prescription of Statin and Low-Density Lipoprotein Cholestrol Treatment Targets in Non-Alcoholic Fatty Liver Disease Petients. Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology GUT2019. (Non-WoS/Non-SCOPUS)
    • Lee C.C., Alex H.R., & Chan W.K. (2019). Fibroscan as a Non-Invasive Approach to Predict the Presence and Size of Varices in the Malaysian Cirrhotic Population. Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology GUT2019. (Non-WoS/Non-SCOPUS)
    2018
    • Andrieux-Meyer,I.,Tan, S-S., Salvadori,N., Simon, F., Cressey, T.R., Said,H.R.H.M.A.,... & Murad, S. (2018).Safety and efficacy of ravidasvir plus sofosbuvir 12 weeks in non-cirrhotic and 24 weeks in cirrhotic patients with hepatitis C virus genotype 1,2,3,and 6 The STORM-C-1 phase IIIII trial. Journal of Hepatology, 68 (1),S123. https://doi.org/10.1016/S0168-8278(18)30428-8 (WoS)
    • Lai, L.L., Vethakkan, S., Mustapha, N.R.N., Mahadeva, S., Chan, W.K. (2018). A pilot study of empagliflozin for the treatment of non-alcoholic steatohepatitis in patients with type 2 diabetes mellitus. Journal of Hepatology, 68 (1), S110. https://doi.org/10.1016/S0168-8278(18)30428-8 (WoS)
    • House, M., Lai, L.L., Chan, W.K.,Mustapha, N.R.N., Vijayananthan,A., Mahadeva, S., & Pierre, T.S. (2018). A non-invasive biomarker of hepatic inflammation based on magnetic resonance imaging. Journal of Hepatology, 68 (1), S565. https://doi.org/10.1016/S0168-8278(18)31387-4 (WoS)
    • Menon, S.H., Lai, L.L., Chan, W.K.,Mustapha, N.R.N., Vijayananthan,A., & Mahadeva, S. (2018). Comparison of HepaFat-Scan and controlled attenuation parameter for the estimation of hepatic steatosis in patients with non-alcoholic fatty liver disease using histology as the reference standard. Journal of Hepatology, 68 (1), S569 S570. https://doi.org/10.1016/S0168-8278(18)31396-5. (WoS)
    • Charing Chong, Sundeep Lakhtakia, Kazuo Hara et al.(2018) Macroscopic On-site Quality Evaluation (MOSE) of Biopsy Specimens to Improve The Diagnostic Accuracy During EUS-Guided FNA Using a 19G Needle for Solid Lesions: A Prospective Randomized Controlled Study. Proceeding of Gastrointestinal Endoscopy, 87(6), AB319. doi.org/10.1016/j.gie.2018.04.1688 (Non-WoS/Non-SCOPUS)
    • Harry, S., Vijayananthan, A., Chan, W.K., Rahmat, K., Faridah, Y. (2018) A Comparison of the Hepafat-Scan and Fibroscan Controlled Attenuation Parameter in the Estimation of Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease Using Histology as the Reference Standard, Annual Scientific Meeting of MSGH (GUT2018), 85. (Non-WoS/Non-SCOPUS)
    • Chan, W.K (2018) Current Therapies - What Has Promise? What Does Not?. Annual Scientific Meeting of MSGH (GUT2018), 41 (Non-WoS/Non-SCOPUS)
    • Chung, Y.C., Tan, S.S., Chan, W.K., Chin, K.T., Hoe, C.H., Lee, Y.Y. (2018) Direct Acting Anti-Viral (DAA) in Hepatitis C Virus (HCV) Patients: Early Real-World Data From Malaysia. Annual Scientific Meeting of MSGH (GUT2018). 71 (Non-WoS/Non-SCOPUS)
    • Lai, L.L., Vethakkan, S. R., Nik Mustapha, N.R., Mahadeva, S., Chan, W.K. (2018) Empagliflozin for the treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes Mellitus. Annual Scientific Meeting of MSGH (GUT2018), 58 (Non-WoS/Non-SCOPUS)
    • Lai, L.L., Wan Yusoff, W.N.I., Vethakkan, S.R., Nik Mustapha, N.R., Chan W.K., (2018) Screening for Non-alcoholic Fatty Liver Disease and Advance Liver Fibrosis in Patients with Type 2 Diabetes Mellitus Using Controlled Attenuation Parameter and Liver Stiffness Measurements. Annual Scientific Meeting of MSGH (GUT2018). 59 (Non-WoS/Non-SCOPUS)
    • Leong, W.L., Lai, L.L., Nik Mustapha, N.R., Vijayananthan, A., Rahmat, K., Mahadeva, S., Chan, W.K. (2018) Comparing Shear Wave Elastography and Transient Elastography for the Diagnosis of Fibrosis Stages in Patients with Non-alcoholic Fatty Liver Disease Using Liver Biopsy as the Reference Standard. Annual Scientific Meeting of MSGH GUT 2018, 43. (Non-WoS/Non-SCOPUS)
    2017
    • Sivesh K Kamarajah, Wah Kheong Chan, Nik Raihan Mustapha, Sanjiv Mahadeva, Outcomes of Biopsy-Proven Non-Alcoholic Fatty Liver Disease (NAFLD) in South East Asian Patients: A Single Tertiary Center Experience, Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2017, Page 36 (Non-WoS/Non-SCOPUS)
    • Pitisuttithum, P., Chan, W. K., Imajo, K., Nakajima, A., Seki, Y., Kasama, K., Kakizaki, S., Fan, J. G., Song, M. J., Yoon, S. K., Dan, Y. Y., Lesmana, L. A., Ho, K. Y., Goh, K. L., Wong , V., Treeprasertsuk, S. (2017).The high prevalence and predictors of advance fibrosis in elderly patients with liver biopsy confirmed non-alcoholic fatty liver disease (NAFLD)-The GOASIA STUDY, American association for the study of liver disease 2017, pg S-1199. (Non-WoS/Non-SCOPUS)
    • Wah Kheong Chan , Sombat Treeprasertsuk , Kento Imajo , Atsushi Nakajima , Yosuke Seki , Kazunori Kasama , Satoru Kakizaki , Jian Gao Fan , Myeong Jun Song , Seung Kew Yoon , Yock Young Dan , Laurentius Lesmana , Khek Yu Ho , Khean Lee Goh , Vincent Wai Sun Wong (2017) Non-alcoholic fatty liver disease- demographic features, risk factors and treatment practices across the Asia Pacific region-the GOASIA initiative, American association for the study of liver disease 2017. (Non-WoS/Non-SCOPUS)
    • Lai LL, Chan WK, Sthaneshwar P, Nik Mustapha NR, Goh KL, Mahadeva S. Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein as a serum biomarker for disease severity in nonalcoholic fatty liver disease. J Hepatol; 66(1): S676. . (WoS)
    • Chan WK, Treeprasertsuk S, Imajo K, Nakajima A, Seki K, Kasama K, Kakizaki S, Fan JG, Song MJ, Yoon SK, Dan YY, Lesmana L, Ho KY, Goh KL, Wong VWS. Non-alcoholic fatty liver disease demographic features, risk factors and treatment practices across the Asia Pacific region the GO ASIA initiative. J Hepatol 2017; 66(1): S595. (WoS)
    • Sumitra Ropini Karuthani, Wah Kheong Chan, Peng Soon Koh, Karuthan Chinna, Comparing the BCLC and HKLC staging systems in the management of hepatocellular carcinoma in a tertiary center in Malaysia, J Gastroenterol Hepatol 2017; 32 (Suppl. 3): 154-194. (WoS)
    • Yeong Yeh Lee, Jianyi Calvin Koh, Mung Seong Wong, Rona Marie Lawenko, Sombat Treeprasertsuk, Siok Chiang Fan, Wai Mun Loo, Wah Keong Chan, Vincent WS Wong, Ajay Duseja, Sutep Gonlachanvit, Murdani Abdullah, Yeon-Young Chuah, Jose Sollano, Myung-Gyu Choi, Kentaro Sugano, Khean Lee Goh, Khek Yu Ho, Dan Yock Young, GO ASIA WORKING GROUP, Perception and bariatric practices of obesity-related gastrointestinal (GI) disease among Asian GI practitioners: GOASIA working group initiative, J Gastroenterol Hepatol 2017; 32 (Suppl. 3): 26-28. (WoS)
    • Wah Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva, Vincent Wai-Sun Wong, Jenny Yeuk-Ki Cheng, Grace Lai-Hung Wong, Do same cut-off values for controlled attenuation parameter (CAP) apply for both M probe and Xl probe of transient elastography (FibroScan )?, J Gastroenterol Hepatol 2017; 32 (Suppl. 3): 154-194. (WoS)
    • Wah Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva, Vincent Wai-Sun Wong, Jenny Yeuk-Ki Cheng, Grace Lai-Hung Wong, Do same cut-off values for controlled attenuation parameter (CAP) apply for both M probe and Xl probe of transient elastography (FibroScan )?Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2017, Page 43 (Non-WoS/Non-SCOPUS)
    • Stanley Khoo, Wah Kheong Chan, KL Goh, A Substantial Proportion of Patients with Chronic Hepatitis B have Significant Fibrosis and Concomitant Fatty Liver: Results from a Cross-Sectional Study Using FibroScan at Major Tertiary Hospital in Malaysia, Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2017, Page 41 (Non-WoS/Non-SCOPUS)
    • Wah Kheong Chan, Management of NAFLD case discussion. Paper presented at the MEMS Annual Congress 2017 (MAC 8), (Non-WoS/Non-SCOPUS)
    2016
    • Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. A randomized, double-blind, placebo- controlled trial of silymarin for the treatment of non-alcoholic steatohepatitis. Hepatol Int 2016; 10 (Suppl 1.): S455. (WoS)
    • Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Silymarin Improves Fibrosis In Non-Alcoholic Steatohepatitis. J Hepatol 2016; 64 : S225-226. (WoS)
    • Wah-Kheong Chan, Kee-Ying Yeoh, Chia-Ying Lim, Su-Meng Lai, Jac-Lyn Lee, Alex Hwong-Ruey Leow, Khean- Lee Goh. A Study on Transmission of Hepatitis B Virus Infection Among Children of Hepatitis B Surface Antigen Positive Mothers from A tertiary Hospital in Malaysia. Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2016, Page 56 (Non-WoS/Non-SCOPUS)
    • Stanley Khoo, Wah Kheong Chan, Sanjiv Mahadeva, Nik Raihan Nik Mustapha. Serum Cathepsin D and Cytokeratin-18 Levels for Lobular Inflammation and Balloning in Adult NAFLD Patients: Non Invalsive Biomarkers in Diagnosis of Non Alcoholic Steatohapetitis (NASH) In Adult patients.Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2016, Page 68 (Non-WoS/Non-SCOPUS)
    • Ruveena Rajaram & Wah-Kheong Chan. Is Silymarin Useful for the Treatment of Non- Alcoholic Fatty Liver Disease?: A Meta Analysis. Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2016, Page 76 (Non-WoS/Non-SCOPUS)
    • Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Serum Aspartate Aminotransferase Levels As A Predictor of Histological Improvement in Patients with Non-Alcoholic Steatohepatitis : Results from A Randomized, Double- Blinded, Placebo- Controlled Study. Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2016, Page 80 (Non-WoS/Non-SCOPUS)
    • Wah Kheong Chan. (2016, Nov). An Asian Multicentre Study On Biopsy-Proven NAFLD Patients-Part of The GO ASIA Initiative.Paper presented at the Asian Pacific Digestive Week APDW 2016, Kobe, Japan.
    • Wah Kheong Chan. (2016, Nov). New Therapeutic Options for NAFLD.Paper presented at the Asian Pacific Digestive Week APDW 2016, Kobe, Japan.
    • Chan, W.K., Yeoh, K.Y.,LIM, C.Y., LAIL, S.M., Lee, J.L., Leow, A.H.R.,...& Goh, K.H. (2016). Hepatitis B Virus Infection Among Children of Hepatitis B Surface Antigen Positive Mothers In A Tertiary Hospital In Malaysia. Proceedings of the Asian Pacific Digestive Week APDW 2016 31, 356. 10.1111/jgh.13540 (WoS)
    • Li, E.T.C., Tai, S.M.L., Chan, W.K., Abd Rahman, R. & Mahadeva, S. (2016). A Study of Non-Alcoholic Fatty Liver Disease Using Transient Elastography and Carotid Intima Media Thickness Using Ultrasonography in a Middle-aged Malaysian Population. Proceedings of the Asian Pacific Digestive Week APDW 2016 31, 385. 10.1111/jgh.13540 (WoS)
    • Khoo,S.,Chan, W.K., Mahadeva, S. & Nik Mustapha, N.R.(2016). Serum Cathepsin D and Cytokeratin-18 Levels for Lobular Inflammation and Ballooning and Adult NAFLD Patients: Non-invansive Biomarkers in Diagnosis of Non-Alcoholic Steatohapetitis (NASH) in Adult Patients. Proceedings of the Asian Pacific Digestive Week APDW 2016 31, 389. 10.1111/jgh.13540 (WoS)
    • Chan, W.K., Nik Mustapha, N.R., & Mahadeva, S. (2016). Serum Aspartate Aminotransferase Levels As A Predictor of Histological Improvement in Patients with Non-Alcoholic Steatohepatitis : Results from A Randomized, Double- Blinded, Placebo- Controlled Study. Proceedings of the Asian Pacific Digestive Week APDW 2016 31, 356. 10.1111/jgh.13540 (WoS)
    • E.C.L. Tan, S.M.L. Tai, Wah-kheong Chan, Sanjiv Mahadeva. A Study of Non-Alcoholic Fatty Liver Disease Using Trasient Elastography and Carotid Intima Media Thickness Using Ultrasonography in a Middle-Aged Malaysian Cohort. Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2016, Page 62 (Non-WoS/Non-SCOPUS)
    2015
    • Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Silymarin for the treatment of non-alcoholic steatohepatitis: interim analysis of a randomized, double-blind, placebo-controlled trial. J Gastroenterol Hepatol 2015; 30 (Suppl. 4): 324. (WoS)
    • Wah-Kheong Chan, Nik Raihan Nik Mustapha. Sanjiv Mahadeva. Silymarin for the treatment of non- alcoholic steatohepatitis: interim analysis of a randomized, double-blind, placebo-controlled trial. Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2015, page 34 (Non-WoS/Non-SCOPUS)
    • Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Is controlled attenuation parameter with the XL probe more accurate than the M probe for estimation of hepatic steatosis in patients with non-alcoholic fatty liver disease? Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2015, page (Non-WoS/Non-SCOPUS)
    • Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Is controlled attenuation parameter with the XL probe more accurate than the M probe for estimation of hepatic steatosis in patients with non-alcoholic fatty liver disease? J Gastroentrol Hepatol 2015; 30 (Suppl. 4): 327. (WoS/SCOPUS)
    • Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Silymarin for the treatment of non-alcoholic steatohepatitis: interim analysis of a randomized, double-blind, placebo-controlled trial. J Hepatol 2015; 62(2): S269. (WoS)
    • Wah-Kheong Chan, Pavai Sthaneshwar, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers. Hepatol Int 2015; 9 (Suppl 1): S362. (WoS)
    • Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. A novel 2 step approach combining the NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis. Hepatol Int 2015; 9 (Suppl 1): S372-3. (WoS)
    • Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Silymarin for the treatment of non-alcoholic steatohepatitis: interim analysis of a randomized, double-blind placebo-controlled trial. EMJ Hepatol 2015; 3(2): 84-6. (Non-WoS/Non-SCOPUS)
    2014
    • Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Combination of NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis in non-alcoholic fatty liver disease. Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2014, page 48 (Non-WoS/Non-SCOPUS)
    • Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in non-alcoholic fatty liver disease. Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2014, page 49. (Non-WoS/Non-SCOPUS)
    • Wah-Kheong Chan, Pavai Sthaneshwar, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers. Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2014, page 50. (Non-WoS/Non-SCOPUS)
    • Wah-Kheong Chan, Pavai Sthaneshwar, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers. J Gastroenterol Hepatol. 2014; 29 (Suppl. 3): 182-3. (WoS)
    • Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Combination of NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2014; 29 (Suppl. 3): 183-4 (WoS)
    • Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in non-alcoholic fatty liver disease. Hepatol Int. 2014; 8(Suppl. 1): 353-4. (WoS)
    2013
    • Wah-Kheong Chan, Najib Azmi, Sanjiv Mahadeva, Khean-Lee Goh. Reduced-volume PEG-ELS plus bisacodyl split- dose is better than same morning whole-dose for morning outpatient colonoscopy: result of an investigator- and endoscopist-blinded, randomized study. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, page 72. (Non-WoS/Non-SCOPUS)
    • Wah-Kheong Chan, Alexander Tong-Boon Tan, Shireene Ratna Vethakkan, Pei-Chien Tah, Anushya Vijayananthan, Khean-Lee Goh. Ultrasonography-diagnosed non-alcoholic fatty liver disease (NAFLD) is not associated with prevalent ischemic heart disease (IHD) among long- standing poorly controlled diabetics. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, page 55. (Non-WoS/Non-SCOPUS)
    • Wah-Kheong Chan, Norhaniza Bahar, Hamizah Razlan, Anushya Vijayananthan, Pavai Sithaneshwar, Khean-Lee Goh. Non-alcoholic fatty liver disease in young adults worrying ethnic differences in a multi-racial Asian population in Malaysia. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, page 56. (Non-WoS/Non-SCOPUS)
    • Wah-Kheong Chan, Alexander Tong-Boon Tan, Vethakkan Shireene Ratna, Pei-Chien Tah, Vijayananthan Anushya, Khean-Lee Goh. Low physical activity and high percentage calorie intake from fat, high cholesterol food and high saturated fatty acid food is associated with NAFLD in centrally obese diabetics. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, page 57. (Non-WoS/Non-SCOPUS)
    • Wah-Kheong Chan, Ida Normiha Hilmi, Phaik-Leng Cheah, Khean-Lee Goh. Progression of non-alcoholic fatty liver disease (NAFLD) a prospective clinicopathological follow-up study. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, page 42. (Non-WoS/Non-SCOPUS)
    • Ahmad Najib Azmi, Wah-Kheong Chan, Sanjiv Mahadeva, Khean-Lee Goh. Split versus whole-dose PEG-ELS for bowel preparation in outpatient colonoscopy. J Gastroenterol Hepatol 2013; 28 (Suppl. 3): 29. (WoS)
    • Wah-Kheong Chan, Norhaniza Bahar, Hamizah Razlan, Anushya Vijayananthan, Pavai Sthaneshwar, Khean-Lee Goh. Prevalence of NAFLD and associated factors among multi- racial Malaysian population. J Gastroenterol Hepatol 2013; 28 (Suppl. 3): 407. (WoS)
    • Wah-Kheong Chan, Alexander Tong-Boon Tan, Shireene Ratna Vethakkan, Pei Chien Tah, Anushya Vijayananthan, Khean-Lee Goh. Ultrasonography-diagnosed NAFLD is not associated with IHD among long-standing poorly- controlled diabetics. J Gastroenterol Hepatol 2013; 28 (Suppl. 3): 407. (WoS)
    2012
    • W K Chan, P L Cheah, I N Hilmi, K L Goh. Clinical and histological follow-up of a cohort of patients with NAFLD. J Gastroenterol Hepatol 2012; 27 (Suppl. 5): 242. (WoS)
    • W K Chan, A T B Tan, S R Vethakkan, P C Tah, A Vijayananthan, K L Goh. The role of diet and physical activity in non-alcoholic fatty liver disease (NAFLD) in diabetic patients. Proceeding The 3rd Asian-Pacific Topic Conference, page 175. (Non-WoS/Non-SCOPUS)
    • W K Chan, A T B Tan, S R Vethakkan, P C Tah, A Vijayananthan, K L Goh. Prevalence of NAFLD among diabetic patients in the outpatient clinic of a Malaysian hospital and associated factors. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology - GUT 2012, page 55. (Non-WoS/Non-SCOPUS)
    • W K Chan, A C Roslani, C W Law, K L Goh, S Mahadeva. Endoluminal clipping versus surgery in the management of iatrogenic colonic perforation: a direct cost analysis. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology - GUT 2012, page 117. (Non-WoS/Non-SCOPUS)
    2011
    • A N Azmi, W K Chan, S H Ho, K L Goh. Patient satisfaction of outpatient gastroscopy in University of Malaya Medical Centre endoscopy unit. J Gastroenterol Hepatol 2011; 26 (Suppl. 5): 58. (WoS)
    • W K Chan, A C Roslani, K L Goh, S Mahadeva. Iatrogenic colonic perforations during colonoscopy: incidence, management and outcome in a Malaysian tertiary hospital. J Gastroenterol Hepatol 2011; 26 (Suppl. 5): 117. (WoS)
    • W K Chan, A C Roslani, K L Goh, S Mahadeva. Iatrogenic colonic perforations during colonoscopy: incidence, management and outcome in a Malaysian tertiary hospital. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology - GUT 2011, page 68. (Non-WoS/Non-SCOPUS)
    • N A Azmi, W K Chan, S H Ho, K L Goh. Patient satisfaction of outpatient gastroscopy in University Malaya Medical Centre endoscopy unit. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology - GUT 2011, page 46. (Non-WoS/Non-SCOPUS)
    2010
    • W K Chan, A Saravanan, J Manikam, K L Goh, S Mahadeva. Risk factors for poor bowel preparation and its impact on technical performance and patient comfort in an Asian population. J Gastroenterol Hepatol 2010; 25(Suppl. 2): A61. (WoS)
    • W K Chan, K L Goh. Patient satisfaction with various aspects of an outpatient colonoscopy service. J Gastroenterol Hepatol 2010; 25 (Suppl. 2): A60. (WoS)
    Editorial Material
    2022
    • Chan, W. K., & Wong, V. W. S. (2022). Meaning of non overlapping patients between the MAFLD and NAFLD definitions. [Editorial]. Liver International, 42(2), 271-273.
    2021
    • Pan, Z., Chan, W. K., & Eslam, M. (2021). The role of B cells in metabolic (dysfunction)-associated fatty liver disease. [Editorial]. Hepatobiliary Surgery and Nutrition, 10(6), 875.
    • Chan, W.K. and Wong, V.W.-S. (2021). Editorial: metagenome-assembled genomes in non-alcoholic fatty liver disease. [Editorial]. Aliment Pharmacol Ther, 53: 755-756. https://doi.org/10.1111/apt.16280.
    • Tan, S. S., Lee, Y. Y., Ali, R. A. R., Mustapha, F., & Chan, W. K. (2021). Endorsing the redefinition of fatty liver disease. [Editorial]. The Lancet Gastroenterology & Hepatology, 6(3), 163. https://doi.org/10.1016/S2468-1253(21)00002-9.
    • Goh, G.B.-B., Chan, W.K. and Wong, V.W.-S. (2021), Breastfeeding to Prevent NAFLD. [Editorial]. Hepatology. https://doi.org/10.1002/hep.32095.
    Meeting Abstract
    2021
    • Yu, M. L., El Kassas, M., Yilmaz, Y., Fernandez, M. C., Buti, M., Papatheodoridis, G., ... & Younossi, Z. M. (2021). Sa313 Clinical presentation and patient-reported outcomes in patients with chronic viral hepatitis: data from the Global Liver Registry . Gastroenterology, 160(6), S-821.
    • Younossi, Z. M., Ong, J. P., Takahashi, H., Yilmaz, Y., Eguchi, Y., El Kassas, M., ... & Council, G. N. S. (2021). A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology.
    • Younossi, Z. M., Yilmaz, Y., Yu, M. L., Wong, V., Fernandez, M. C., Isakov, V., ... & Stepanova, M. (2021). 342 Clinical presentation of lean non-alcoholic fatty liver disease (NAFLD) across the world: data from the Global NASH Registry. Gastroenterology, 160(6), S-771.
    RESEARCH PROJECT
    (Project title),(Role),(Duration),(Level)
    Private Funding
  • A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis, Principal Investigator(PI), 2017 - 2023 (International)
  • Open label phase II/III, multicenter, trial to assess the efficacy, safety, tolerance, and pharmacokinetics of sofosbuvir plus ravidasvir in HCV (+/- HIV) chronically infected adults with no or compensated cirrhosis in Thailand and Malaysia, Consultant, 2016 - 2018 (National)
  • Validation of a MRI-based classification of hepatic fibrosis, Principal Investigator(PI), 2016 - 2017 (International)
  • Mac-2 binding protein glycosylation isomer for diagnosis of NASH and fibrosis in patients with NAFLD, Principal Investigator(PI), 2016 - 2017 (International)
  • EndoBarrier SANS in Over-weight or Obese Type 2 Diabetic Subjects , Principal Investigator(PI), 2015 - 2015
  • NONE
  • Validation of 2-step approach in non-invasive assessment of NAFLD, Principal Investigator(PI), 2017 - 2019 (International)
  • Macroscopic on-site quality evaluation of biopsy specimens to improve the diagnostic accuracy during EUS-guided FNA using a 19-gauge needle for solid lesions: a multicenter prospective randomized controlled study, Consultant, 2016 - 2016
  • Gut and Obesity in Asia: Spectrum of non-alcoholic fatty liver disease in Asia: a retrospective cohort study, Consultant, 2016 - 2016
  • Controlled attenuation parameter using Fibroscan XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease, Principal Investigator(PI), 2015 - 2015
  • Prognostication of non-alcoholic fatty liver disease using controlled attenuation parameter and liver stiffness measurement by Fibroscan , Consultant, 2015 - 2020
  • A study on the vertical transmission of hepatitis B virus infection in Malaysia, Principal Investigator(PI), 2014 - 2015
  • Integrating non-invasive methods for assessment of patients with non-alcoholic fatty liver disease, Principal Investigator(PI), 2013 - 2015 (National)
  • Randomized study on split-dose versus whole-dose polyethylene glycol electrolyte lavage solution plus bisacodyl for bowel preparation for adult patientsundergoing outpatient colonoscopy, Consultant, 2013 - 2014 (National)
  • Prevalence of non-alcoholic fatty liver disease (NAFLD) and associated factros in a young, multi-racial Malaysian population., Principal Investigator(PI), 2012 - 2013 (National)
  • Iatrogenic Colonic Perforation: A 6-year Single Centre Experience of Endoscopic and Surgical Management , Principal Investigator(PI), 2011 - 2011
  • Evaluation of Patient Satisfaction of an Outpatient Colonoscopy Service in an Asian Tertiary Care Hospital. , Principal Investigator(PI), 2010 - 2010
  • A validation study of the Leeds Dyspepsia Questionnaire in a multi-ethnic Asian population., Consultant, 2010 - 2010
  • Pharmaceutical
  • CELSION OPTIMA, Consultant, 2014 - 2015 (International)
  • The Swami Institute for International Medical Education Grant
  • Molecular and metabolic distinction of non-alcoholic fatty liver disease and type 2 diabetes mellitus, Consultant, 2013 - 2014 (International)
  • Geran Penyelidikan Universiti Malaya (UMRG)
  • Validation of the Enhanced Liver Fibrosis panel for estimation of fibrosis in patients with non-alcoholic fatty liver disease, Consultant, 2013 - 2014 (National)
  • Prevalence of Fatty Liver among Outpatient Diabetic Patients in an Asian Tertiary Care Hospital , Principal Investigator(PI), 2011 - 2012 (National)
  • Madaus GmbH
  • A Randomized, Double-Blind, Placebo-Controlled,Phase II, Single-Centre Study to Evaluate theSafety and Efficacy of Silymarin 700 mg TID forthe Treatment of Non-Alcoholic Fatty Liver Disease, Consultant, 2012 - 2014 (National)
  • Celsion
  • A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of Thermodox (Thermally Sensitive Liposomal Doxorubicin) in Combination with Radiofrequency Ablation (RFA) Compared to RFA Alone in the Treatment of Non-Resectable Hepatocellular Carcinoma , Consultant, 2010 - 2012
  • MSGH Research Grant
  • Clinical and Histological Follow-Up of Cohort ofPatient with Non-Alcoholic Fatty Liver Disease, Principal Investigator(PI), 2010 - 2013 (National)
  • Evaluation of Patient Satisfaction of an Outpatient Gastroscopy Service in an Asian Tertiary Care Hospital , Consultant, 2010 - 2011 (National)
  • SUPERVISION
    Postgraduate Student
    (Title of Thesis),(Name of Candidates),(Institution),(Academic Level)
    Completed
    • A study of non-alcoholic fatty liver disease using transient elastography and carotid intima media thickness using ultrasonography, Eugene Tan Choon Li, University of Malaya (UM) (Post Graduate Student)
    • Clinical Fellows in Gastroenterology, Dr. Suresh Sithambaram, University of Malaya (UM) (Post Graduate Student)
    • Masters Degree in Internal Medicine, Nor Suraya Samsudin, University of Malaya (UM) (Post Graduate Student)
    • Patient Satisfaction of Outpatient Gastroscopy in University Malaya Medical Centre Endoscopy Unit, Ahmad Najib bin Azmi, University of Malaya (UM) (Post Graduate Student)
    Ongoing
    • Fibroscan as a non-invasive approach to predict the presence and size of varices in the Malaysian cirrhotic population, Lee Chong Chearn, University of Malaya (UM) (Post Graduate Student)
    • MRI-based classification of liver fibrosis, Syaman a/l Harry, University of Malaya (UM) (Post Graduate Student)
    • Shear wave elastography imaging for assessment of liver fibrosis in non-alcoholic fattyliver disease: correlation with transient elatography and histopathologic evaluation, Leong Wai Ling, University of Malaya (UM) (Post Graduate Student)
    • Prevalence of advanced fibrosis due to non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus, Lai Lee Lee, University of Malaya (UM) (Post Graduate Student)
    • Fibroscan as a non-invasive approach to predict the presence and size of varices in the Malaysian cirrhotic population, Kavitha A/P Sahadivanaidu, University of Malaya (UM) (Post Graduate Student)
    • SARJANA PERUBATAN DALAMAN, Leong Lai Kuan, University of Malaya (UM) (Post Graduate Student)
    • Sarjana Perubatan Dalaman, Ang Chui Mun, University of Malaya (UM) (Post Graduate Student)
    UG Student/Clinical Fellowship
    (Title of Thesis),(Academic Session)
    Completed
    • MBBS, Yeoh Whei Chuern, Prevalence of fatty liver among outpatient diabetic patients in an Asian tertiary care hospital, 2011/2012
    • MBBS, Ooi Chung Ping, Risk factors for fatty liver among outpatient diabetic patients in an Asian tertiary care hospital, 2011/2012
    • MBBS, Choo Pee Terh, Randomized controlled trial: effect of split-dose versus whole-dose 2-liter polyethylene glycol electrolyte lavage solution (PEG-ELS) on patient tolerability of bowel preparation for colonoscopy, 2012/2013
    • MBBS, Tan Wen Nian, Randomized controlled trial: effect of split-dose versus whole-dose 2-liter polyethylene glycol electrolyte lavage solution (PEG-ELS) on quality of bowel preparation for colonoscopy, 2012/2013
    • MBBS, Ong Jes Mon, 2013/2014
    • MBBS, Tan Zhun Foo, 2013/2014
    • MBBS, Andrew Yeoh, A study on the vertical transmission of hepatitis B virus infection in Malaysia, 2014/2015
    • MBBS, Moh Jun Yuan, 2013/2014
    • MBBS, Lai Su Meng, A study on the vertical transmission of hepatitis B virus infection in Malaysia, 2014/2015
    • MBBS, Stacey Lim, A study on the vertical transmission of hepatitis B virus infection in Malaysia, 2014/2015
    • MBBS, Jaclyn Lee, A study on the vertical transmission of hepatitis B virus infection in Malaysia, 2014/2015
    Ongoing
    • MBBS, Sumitra Ropini, A review of hepatocellular carcinoma from 2011 to 2014 in University Malaya Medical Centre, 2015/2016
    • Mentor for MBBS Programme Kee Yan Shen, 2017/2018
    SOCIAL RESPONSIBILITY ACTIVITIES
    (Contribution to Society),(Duration),(Level)
    • Chairperson to VIRTUAL GUT 2020-Annual Scientific Meeting of MSGH, 27/11/2020 to 29/11/2020
    • Moderator for Bariatric Endoscopy Live Global , 02/10/2020 to 02/10/2020
    • Organizing committee for Asia Pacific Digestive Week 2020, 17/09/2020 to 20/09/2020
    • Organising committee of Asian Pacific Digestive Week 2020 as the Scientific Co-Chair-Hepatology, 17/09/2020 to 20/09/2020
    • Bid Committee for Asia Pacific Digestive Week 2020, 17/09/2020 to 20/09/2020
    • Moderator for Web Symposium SEA NAFLD Summit 2020, 28/07/2020 to 28/07/2020
    • Chairperson for Live Webinar: "Find the Missing Millions" (Advanced Treatments for Hepatitis), 26/07/2020 to 26/07/2020
    • Chairperson for Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology GUT2019 , 16/08/2019 to 18/08/2019
    • Chairperson for Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology GUT2019, 16/08/2019 to 18/08/2019
    • Organizing Committe for Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology GUT2019, 16/08/2019 to 18/08/2019
    • Organizing Committee for Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology (GUT 2018), 13/07/2018 to 15/07/2018
    • Organizing committee for Annual Scientific Meeting MSGH (GUT 2018), 13/07/2018 to 15/07/2018
    • Chairperson for Hepatitis B Tea Satellite Symposium (GUT 2018), 13/07/2018 to 15/07/2018
    • Chairperson for Hepatitis B Symposium (GUT 2018), 13/07/2018 to 15/07/2018
    • Co-Course Director for Basic EUS Course 2018, 06/04/2018 to 06/04/2018
    • Co-Course Director for Endoscopy 2018, 06/04/2018 to 08/04/2018
    • Organizing Committee for MSGH Update in Gastroenterology and Hepatology 2018, 03/03/2018 to 03/03/2018
    • Organizing Committee for GUT 2017, 11/08/2017 to 13/08/2017
    • Chairperson for GUT 2017, 11/08/2017 to 13/08/2017
    • Chairperson of Annual Scientific Meeting of the Indian National Association for Study of the Liver (25th silver jubilee) 2017, 05/08/2017 to 05/08/2017
    • Chairperson for Hot Topics in Hepatology Symposium , 02/06/2017 to 03/06/2017
    • Coordinator for Endoscopy 2017, 07/04/2017 to 09/04/2017
    • Course Co-Directors for Endoscopy 2017, 07/04/2017 to 09/04/2017
    • Organizing Committee for Endoscopy 2017, 07/04/2017 to 09/04/2017
    • Organizing Committee for MSGH Update in Gastroenterology and Hepatology, 04/03/2017 to 04/03/2017
    • Chairperson in Asian Pacific Digestive Week APDW 2016, 02/11/2016 to 05/11/2016
    • Organizing Committee GUT 2016, 22/07/2016 to 24/07/2016
    • Chairperson for GUT 2016, 22/07/2016 to 24/07/2016
    • Organizing Committee for Endoscopy 2016, 08/04/2016 to 10/04/2016
    • Co-Course Director for EUS-Cytopathology Hands-On Workshop 2015, 21/12/2015 to 21/12/2015
    • Organizing Committee for 2015 Advanced EUS Workshop, 21/12/2015 to 21/12/2015
    • Organizing Committee for Endoscopy 2015: Maintaining Quality in Endoscopy, 17/04/2015 to 19/04/2015
    • Assistant Course Director for the 2nd Advanced EUS Workshop 2014, 13/10/2014 to 13/10/2014
    • Organizing Committee for Endoscopy 2014: The Best Tips in Therapeutic Endoscopy , 28/03/2014 to 30/03/2014
    • Course Coordinator for Basic Endoscopy Course 2013, 2013
    • Course Coordinator for Gastrointestinal Motility Workshop 2013, 2013
    • Assistant Course Coordinator for Asian EUS Group Workshop 2013, 2013
    • Course Coordinator for GIA Course 2013 , 2013
    • Organizing Committee for Endoscopy 2013: Advancing the Practice of Endoscopy, 12/04/2013 to 14/04/2013
    • Organizing Committee for Endoscopy 2012: Therapeutic Endoscopy in the Global World, 30/03/2012 to 01/04/2012
    • Organizing Committee for 1st ERBE-UMMC Training Workshop in Therapeutic Endoscopy, 01/07/2011 to 01/07/2011
    • Organizing Committee for Endoscopy 2011: What's New and What's Good for Our Patients, 14/04/2011 to 17/04/2011
    ACADEMIC/PROFESSIONAL SERVICES
    Academic/Professional Services
    (Contribution),(Duration),(Level),(Role)
  • Developing an international Delphi consensus on metabolic dysfunction-associated fatty liver disease (MAFLD) and the risk of cardiovascular disease (CVD), 16/08/2022 to 30/09/2022, International, (Expert Advisor)
  • Reviewer for a Manuscript entitled "M-PAST score is better than MAST and FAST for the diagnosis of active fibrotic NASH", 12/08/2022 to 12/08/2022, International, (Reviewer)
  • Participant of a Meeting, 28/07/2022 to 28/07/2022, National, (Participant)
  • Speaker (Managing Fatty Liver in Primary Care) at MEMS Annual Congress, 17/07/2022 to 17/07/2022, International, (Panelist/Moderator)
  • Speaker ('I have fatty liver. What does it mean and what should I do?') at MNCC Online Talk, 16/07/2022 to 16/07/2022, National, (Panelist/Moderator)
  • Reviewer for a manuscript entitled 'MAFLD:What 2 years of the redefinition of fatty liver disease has taught us', 13/07/2022 to 13/07/2022, International, (Reviewer)
  • Speaker (Fatty Liver: What is it and what I can do about it?), 18/06/2022 to 18/06/2022, International, (Panelist/Moderator)
  • Course Coordinator for Young GI Consultant Forum, 03/06/2022 to 04/06/2022, International, (Event Coordinator)
  • Participant of Endoscopy Workshop 2022, 03/06/2022 to 04/06/2022, International, (Participant)
  • Chairperson for Non-Alcoholic Fatty Liver Disease Symposium, 31/05/2022 to 31/05/2022, International, (Panelist/Moderator)
  • Chairperson for Advanced Liver Disease Symposium, 31/05/2022 to 31/05/2022, International, (Panelist/Moderator)
  • Participant for Novo Nordisk Local Investigator Meeting, 21/05/2022 to 21/05/2022, International, (Participant)
  • Panel Reviewer for UMSC CA.R.E Fund (Research Grant) Cycle 1/2022, 10/05/2022 to 10/05/2022, University, (Reviewer)
  • Speaker (Obesity and Fatty Liver) at the Nursing Webinar Session 10/2022, 20/04/2022 to 20/04/2022, University, (Panelist/Moderator)
  • Speaker (Current challenge and opportunity in emerging treament for NAFLD) at the APASL2022, 30/03/2022 to 03/04/2022, International, (Panelist/Moderator)
  • Member of International Collaborative Group, 25/03/2022 to 31/12/2022, International, (Expert Advisor)
  • Reviewer for article in journal, 09/03/2022 to 09/03/2022, International, (Reviewer)
  • Reviewer for two manuscripts, 07/03/2022 to 07/03/2022, International, (Reviewer)
  • Speaker (NAFLD: Placing the liver on diabetes maps) at the Diabetes Malaysia Webinar Series, 25/09/2021 to 25/09/2021, National, (Panelist/Moderator)
  • Speaker ( An update on the management of chronic hepatitis B) at the World Pharmacist Day, 24/09/2021 to 24/09/2021, University, (Panelist/Moderator)
  • Speaker (Obesity and fatty liver) at the Nursing Webinar Session 23/2021, 22/09/2021 to 22/09/2021, University, (Panelist/Moderator)
  • Program director for NAFLD MAFLD SIG Program, 20/08/2021 to 22/08/2021, International, (Event Coordinator)
  • Speaker (Analysis of Continuous Data) during APDWF-JGHF Young Clinician Investigator Program, 19/08/2021 to 22/08/2021, International, (Panelist/Moderator)
  • Chairperson for Ravidasvir: Newer and Better DAA?, 19/08/2021 to 22/08/2021, International, (Panelist/Moderator)
  • Chairperson for NAFLD MAFLD SIG Program 3, 19/08/2021 to 22/08/2021, International, (Panelist/Moderator)
  • Organizing Committee for Virtual APDW 2021, 19/08/2021 to 22/08/2021, International, (Event Organiser)
  • Facilitator for Practical Session during APDWF-JGHF Young Clinician Investigator Program, 19/08/2021 to 22/08/2021, International, (Course Facilitator)
  • Chairperson for NAFLD MAFLD SIG Program 1, 19/08/2021 to 22/08/2021, International, (Panelist/Moderator)
  • Speaker (Case Discussion) for NAFLD MAFLD SIG Program 1 during Virtual APDW 2021, 19/08/2021 to 22/08/2021, International, (Panelist/Moderator)
  • Chairperson for NAFLD MAFLD SIG Program 2, 19/08/2021 to 22/08/2021, International, (Panelist/Moderator)
  • Speaker (Interventional Studies, including Randomized Controlled Trial) during APDWF-JGHF Young Clinician Investigator Program, 19/08/2021 to 22/09/2021, International, (Panelist/Moderator)
  • Reviewer for a manuscript, 11/08/2021 to 11/08/2021, International, (Reviewer)
  • Participant of MEMS Annual Congress 2021, 30/07/2021 to 01/08/2021, National, (Participant)
  • Speaker (My patient has NAFLD - So what??) at MEMS Annual Congress 2021, 30/07/2021 to 01/08/2021, National, (Panelist/Moderator)
  • Examiner for Master's in Internal Medicine Examination, 10/05/2021 to 10/05/2021, University, (Internal Examiner)
  • Speaker (Diet and Exercise: Which One Plays a More Important Role?) at APASL 2021, 04/02/2021 to 06/02/2021, International, (Panelist/Moderator)
  • Speaker (NAFLD-MAFLD: new definition and cardiovascular risk) at APASL 2021, 04/02/2021 to 06/02/2021, International, (Panelist/Moderator)
  • Speaker (NAFLD and T2DM: Two sides of the same coin) at Virtual CGP Management of T2DM, 30/01/2021 to 30/01/2021, National, (Panelist/Moderator)
  • Moderator for session entitled "The landscape for upcoming NASH therapy", 25/01/2021 to 25/01/2021, International, (Panelist/Moderator)
  • Member of international collaborative research group, 17/10/2018 to 31/12/2023, International, (Expert Advisor)
  • Member of international collaborative research group, 01/12/2015 to 31/12/2025, International, (Expert Advisor)
  • Member of international collaborative research group, 25/11/2014 to 31/12/2024, International, (Expert Advisor)
  • AWARD AND STEWARDSHIP
    (Name of Award/Stewardship),(Awarding Institution),(Year Awarded),(Type of Award)
    • Best Paper Award for Second place in the Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2017, Malaysian Society of Gastroenterology and Hepatology, 2017 (RESEARCH)
    • CERTIFICATE OF EXCELLENT SERVICE, University of Malaya, 2017 (CERTIFICATE)
    • Best Paper Award 1st Prize at the Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2016, Malaysian Society of Gastroenterology and Hepatology, 2016 (RESEARCH)
    • CERTIFICATE OF EXCELLENT SERVICE, University of Malaya, 2015 (CERTIFICATE)
    • Best Paper Award 1st Prize at the Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2015, Malaysian Society of Gastroenterology and Hepatology, 2015 (RESEARCH)
    • Asian Young Endoscopist Award 2015, Koran Society of Gastrointestinal Endoscopy, 2015 (OTHERS)
    • APDWF Posters of Distinction Award, Asian Pacific Digestive Week Federation, 2015 (RESEARCH)
    • Best Paper Award 1st Prize at the Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2015, Malaysian Society of Gastroenterology and Hepatology, 2015 (RESEARCH)
    • Poster of Distinction: Controlled attenuation parameter for the detection and quantification of hepatic steatosis in non-alcoholic fatty liver disease,at the 23rd Conference of the Asian Pacific Association in the Study of the Liver 2014, Asian Pacific Association in the Study of the Liver 2014, 2014 (RESEARCH)
    • EXCELLENCE SERVICE AWARD, University of Malaya, 2013 (CERTIFICATE)
    • Best Paper Award 1st Prize at the Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, Malaysian Society of Gastroenterology and Hepatology, 2013 (RESEARCH)
    • Best Paper Award 1st Prize at the Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2012, Malaysian Society of Gastroenterology and Hepatology, 2012 (RESEARCH)
    • Scholarship as Visiting Scholar to Kyushu University Hospital, Kyushu University Hospital, 2011 (SPECIAL)
    CONSULTANCY PROJECT
    (Project title),(Organisation),(Duration),(Role),(Level)
    • Consultant Gastroenterologist, University of Malaya Specialist Centre, 01/12/2014 to 01/12/2020 (National)
    • Reaching a Consensus on Optimising the Use of Nexavar in HCC., Bayer HealthCare Pharmaceuticals, 01/10/2014 to 01/10/2014 (National)
    • Consultant Gastroenterologist, University of Malaya Medical Centre, 01/12/2013 to 01/12/2020 (National)
    PAPER PRESENTED
    (Title),(Event),(Date Presented),(Organiser),(Level)
    PLENARY SPEAKER
  • Prognostic value of LSM measured by FibroScan and Prognostic value of blood markers and focus on FibroMeter, Pronostic value of FibroScan and FibroMeter in Chronic liver diseases, 07/12/2016 to 07/12/2016, Echosens Webinar (International)
  • INVITED SPEAKER
  • Bile acids in the pathogenesis and treatment of NASH, 33rd Annual Scientific Meeting (Webinar) and International Symposium on Hepatology, 29/11/2020 to 29/11/2020, The Hong Kong Association for the Study of Liver Diseases (International)
  • DAA Elimination in Special Population, International Digestive Disease Forum HYBRID 2020, 22/11/2020 to 23/11/2020, Institute of Digestive Disease (IDD) of The Chinese University of Hong Kong (International)
  • Pharmacological Treatments for NAFLD, International Digestive Disease Forum HYBRID 2020, 22/11/2020 to 23/11/2020, Institute of Digestive Disease (IDD) of The Chinese University of Hong Kong (CUHK) (International)
  • Who needs pharmacological treatment?, 20th PGI-AIIMS Current Perspectives in Liver Disease-CPLD 2020 Virtual Conference, 10/10/2020 to 11/10/2020, Department of Hepatology, PGIMER,Chandigarh and Department of Gastroenterology, AIIMS, New Delhi (International)
  • Epidemiology of NASH in Asia Pacific, Asian Pacific Digestive Week 2019 (NASH Symposium), 11/12/2019 to 15/12/2019, Asian Pacific Digestive Week 2019 Kolkata (International)
  • Analysis of continuous data, Asian Pacific Digestive Week 2019, 11/12/2019 to 15/12/2019, Asian Pacific Digestive Week 2019 Kolkata (International)
  • Interventional studies, including randomized controlled trials , Asian Pacific Digestive Week 2019, 11/12/2019 to 15/12/2019, Asian Pacific Digestive Week 2019 Kolkata (International)
  • Emerging Therapy for NAFLD, Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology GUT2019, 16/08/2019 to 18/08/2019, Malaysian Society of Gastroenterology & Hepatology (International)
  • Silymarin in NAFLD, Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology GUT2019, 16/08/2019 to 18/08/2019, Malaysian Society of Gastroenterology & Hepatology (International)
  • Non-invasive diagnosis of liver fibrosis: serological, mechanical or both?, Singapore Hepatology Conference, 07/06/2019 to 08/06/2019, Singapore Hepatology Conference Pte Ltd (International)
  • Optimising Comprehensive Management of NASH, Singapore Hepatology Conference, 07/06/2019 to 08/06/2019, Singapore Hepatology Conference Pte Ltd (International)
  • Moderate alcohol intake in NAFLD: good or bad?, 28th Annual Conference of the Asia Pacific Association for the Study of Liver, 20/02/2019 to 24/02/2019, Asia Pacific Association for the Study of Liver (International)
  • Impact of steatosis on viral hepatitis, 28th Annual Conference of the Asia Pacific Association for the Study of Liver, 20/02/2019 to 24/02/2019, Asia Pacific Association for the Study of Liver (International)
  • Roadblocks to Research - Local Perspectives , Annual Scientific Meeting for the Malaysian Society of Gastroenterology and Hepatology (GUT 2018), 13/07/2018 to 15/07/2018, Malaysian Society of Gastroenterology and Hepatology  (International)
  • Enhancing Patient Care with Fibroscan, Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology (GUT 2018), 13/07/2018 to 15/07/2018, Malaysian Society of Gastroenterology and Hepatology (International)
  • Pathophysiology and risk factors for NAFLD, Singapore Hepatology Conference 2018, 08/06/2018 to 09/06/2018, Singapore Hepatitis Conference Pte Ltd (International)
  • NAFLD- Current Management Strategies, MSGH Update in Gastroenterology and Hepatology, 03/03/2018 to 03/03/2018, Malaysian Society of Gastroenterology and Hepatology (National)
  • What and how common is NAFLD, Latest Update from University Malaya Leading Research Team in NAFLD, 11/11/2017 to 11/11/2017, Milan Pharmaceuticals, Inc (National)
  • Latest Update from University Malaya Leading Research Team in NAFLD, What are the current treatment options for NAFLD , 11/11/2017 to 11/11/2017, Milan Pharmaceuticals, Inc (National)
  • A Practical Approach in the Assessment of NAFLD, Annual Scientific Meeting 2017 (Mastering the Art of Challenging Diagnosis, Minimizing Misses), 09/11/2017 to 12/11/2017, Annual Scientific Meeting of College of Physicians, AMM (National)
  • An Update on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis , MIMS Doctor, Special reports interview., 01/10/2017 to 01/10/2017, MIMS Gastroenterology (International)
  • Epidemiology in Asia-Pacific, Asia Pacific Digestive Week Federation (APDW) 2017 Hong Kong, 23/09/2017 to 26/09/2017, Asian Pacific Digestive Week (APDW) 2017 (International)
  • Racial and ethnic differences in NAFLD, Asia Pacific Digestive Week Federation (APDW) 2017 Hong Kong, 23/09/2017 to 26/09/2017, Asian Pacific Digestive Week (APDW) 2017 (International)
  • Racial and ethnic differences in NAFLD, Annual Scientific Meeting of the Indian National Association for the Study of the Liver 2017 (25th Silver Jubilee), 03/08/2017 to 06/08/2017, Indian National Association for the Study of the Liver (INASL) (International)
  • Identifying Patients At Risk for NAFLD, Singapore Hepatology Conference 2017, 02/06/2017 to 03/06/2017, Singapore Hepatitis Conference Pte Ltd (International)
  • Management of NAFLD case discussion, MEMS Annual Congress 2017 (MAC 8), 19/05/2017 to 21/05/2017, Malaysian Endocrine and Metabolic Society (National)
  • New Pharmacological Treatment for NASH , MSGH Update In Gastroenterology and Hepatology , 04/03/2017 to 04/03/2017, Malaysian Society of Gastroenterology and Hepatology (National)
  • New Pharmacological Treatment for NASH , MSGH Update in Gastroenterology and Hepatology, 04/03/2017 to 04/03/2017, Malaysian Society of Gastroenterology and Hepatology (National)
  • New Solution for NASH Management, 56th Gat Annual Meeting 2016: The Gastroenterological Association Of Thailand, 28/11/2016 to 30/11/2016, The Gastroenterological Association Of Thailand (International)
  • Non-Alcoholic Fatty Liver Disease (NAFLD): Are We Doing Enough?, 15TH CONTINUING PROFESSIONAL DEVELOPMENT (CPD) SERIES : DIABETES ASIA 2016 CONFERENCE, 06/10/2016 to 09/10/2016, NADI : NATIONAL DIABETES INSTITUTE (National)
  • The AASLD Guideline on Hepatitis C Treatment, Hepatitis C Treatment Referral Advisory Board Meeting Agenda , 13/03/2016 to 13/03/2016, LF ASIA  (National)
  • General Concepts and Basic Technique of Esophageal Stenting, GI Stenting Training Course, 09/01/2016 to 09/01/2016, The Digestive Endoscopy Society of Taiwan (International)
  • EUS-FNA: Technique and Improving Yield, ERCP and EUS Proctorship Workshop, 12/10/2015 to 13/10/2015, Sanpya General Hospital (International)
  • Live Case Demonstration, ERCP and EUS Proctorship Workshop , 12/10/2015 to 13/10/2015, Sanpya General Hospital (International)
  • Pathogenesis of NAFLD, Hepato Metabolic GP Workshop, 05/09/2015 to 06/09/2015, MEDA Rottapharm Madaus (National)
  • NAFLD-Pathogenesis , 11th Liver Update 2015 International Conference , 30/07/2015 to 02/08/2015, Malaysian Liver Foundation  (International)
  • Diagnosis and management of non-alcoholic fatty liver disease, EXPERT Summit 2015, 16/05/2015 to 16/05/2015, Sanofi (National)
  • Pathophysiology , Fatty Liver Symposium , 02/11/2014, Malaysian Liver Malaysian (National)
  • Fatty Liver Research Discussion , Fatty Liver Symposium, 02/11/2014, Malaysian Liver Foundation  (National)
  • NAFLD: Cause or Effect?, Diabetes Asia 2014 Conference, 16/10/2014 to 19/10/2014, NADI (National Diabetes Institute) (National)
  • Anti-Viral therapy for secondary and tertiary prevention of HCC, 2014 THOMAS The Hepatic Oncology Multi-Disciplinary Approach Symposium, 11/10/2014 to 12/10/2014, 2014 THOMAS The Hepatic Oncology Multi-Disciplinary Approach Symposium (International)
  • How To Prevent Post-Treatment (RFA, resection, TACE) liver decompensation, 2014 THOMAS The Hepatic Oncology Multi-Disciplinary Approach Symposium, 11/10/2014 to 12/10/2014, 2014 THOMAS The Hepatic Oncology Multi-Disciplinary Approach Symposium (International)
  • Predicting disease progression and mortality in NAFLD , GUT 2014 and ECCO Educational Workshop, 22/08/2014 to 24/08/2014, Malaysian Society of Gastroenterology and Hepatology  (National)
  • Management of GERD; symptoms vs. patient s needs, A to Z Primary Care Updates, 06/07/2014, AstraZeneca, Malaysian Medical Association (Sarawak Branch) (National)
  • Local practice in Malaysia on bowel preparation and what's new, Right from the Start: Clean, clear colon for early detection and accurate medical decision, 23/06/2014, EP Plus Gastro Care (National)
  • An Overview and Practical Management of NAFLD, 7th Postgraduate Course In Hepatology "The Bread & Butter of Liver Disease and Their Management", 26/04/2014, Hepatology Department, Selayang Hospital. Ministry of Health Malaysia (Others)
  • Large Polypectomy/EMR, Endoscopy 2014 - Annual Workshop in Interventional GI Endoscopy, 28/03/2014, University of Malaya (National)
  • Update on NAFLD - what is the latest?, MSGH Update in Gastroenterology and Hepatology, 15/02/2014, Malaysian Society of Gastroenterology and Hepatology (National)
  • Diagnosis and Management of GERD, Pharmacy Summit Meeting, 06/10/2013, Malaysian Pharmaceutical Association and Astra Zeneca (National)
  • Technical aspects of colonic polyp removal, Basic Endoscopy Course 2013, 21/06/2013, University of Malaya (National)
  • Overview of endoscopic management of variceal bleeding, Basic Endoscopy Course 2013, 21/06/2013, University of Malaya (National)
  • Measuring Fibrosis and Cirrhosis in Chronic Hepatitis C: Liver Biopsy and Fibroscan, Preceptorship on Hepatitis C Treatment - Cambodia, 18/02/2013 to 18/02/2013, Roche Cambodia (International)
  • Management of Chronic Hepatitis C in Patient with Chronic Renal Failure, Preceptorship on Hepatitis C Treatment - Cambodia, 17/02/2013 to 17/02/2013, ROCHE Cambodia (International)
  • Improving Outcomes of Patients with Hepatitis C: A Local Perspective, Preceptorship for Hepatitis C Treatment, 07/10/2012 to 07/10/2012, ROCHE (National)
  • Measuring Fibrosis and Cirrhosis in Chronic Hepatitis C: Liver Biopsy and Fibroscan , Preceptorship on Hepatitis C Treatment, 13/08/2012 to 13/08/2012, ROCHE Vietnam and University of Malaya Medical Centre (International)
  • Management of Chronic Hepatitis C in Patient with Chronic Renal Failure, Preceptorship for Hepatitis C Treatment, 12/08/2012 to 12/08/2012, ROCHE Vietnam  (International)
  • Technical Aspect of Colonic Polyp Removal, 1st ERBE-UMMC Training Workshop in Therapeutic Endoscopy,, 01/07/2011 to 01/07/2011, ERBE and University of Malaya Medical Centre (International)
  • Non-alcoholic fatty liver disease: what do we know so far?, 10th Pharmacy Nite Seminar: What Pharmacists Know, 01/08/2010 to 01/08/2010, Malaysian Pharmaceutical Society (National)
  • ORAL PRESENTER
  • Physical activities among patients with nonalcoholic fatty liver disease in Hong Kong, Shanghai, Singapore and Malaysia, 28th Annual Conference of the Asia Pacific Association for the Study of Liver, 20/02/2019 to 24/02/2019, Asia Pacific Association for the Study of Liver (International)
  • Technique of linear radial EUS, Endoscopy 2018 " Therapeutic Endoscopy: Building on Basics", 06/04/2018 to 08/04/2018, Malaysian Society of Gastroenterology and Hepatology (National)
  • A comparison of the HepaFat-Scan and FibroScan controlled attenuation parameter in the estimation of hepatic steatosis in patients with nonalcoholic fatty liver disease using histology as the reference standard, 13Th Asian - Australasian Federation of intervention and Therapeutic Neuroradiology (AAFITN 2018) , 07/03/2018 to 09/03/2018, Asian-Australasian Federation of Interventional and Therapeutic Neuroradiology (AAFITN) (International)
  • Do the same-cut-off values for controlled attenuation parameter (CAP) apply for both M probe and XL probe of transient elastography [Fibroscan]?, Asia Pacific Digestive Week (APDW) 2017 Hong Kong, 23/09/2017 to 26/09/2017, Asia Pacific Digestive Week (APDW) 2017 (International)
  • Comparing the BCLC and HKLC Staging System in the Management of Hepatocellular Carcinoma in a Tertiary Center in Malaysia, Annual Scientific Congress Malaysian Society of Gastroenterology and Hepatology, GUT 2017, 11/08/2017 to 13/08/2017, Malaysian Society of Gastroenterology and Hepatology (National)
  • A randomized, double-blind, placebo-controlled study on silymarin for the treatment of non-alcoholic steatohepatits, The 25th Conference of the Asia Pacific Association for the Study of the Liver, 23/02/2016 to 23/02/2016, The Asia Pacific Association for the Study of the Liver (International)
  • Silymarin for the treatment of Non-Alcoholic Steatohepatitis: Interim Analysis of a Randomized, Double-Blind,Placebo-Controlled Trial, Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2015, 21/08/2015 to 23/08/2015, Malaysian Society of Gastroenterology and Hepatology (National)
  • Progression of non-alcoholic fatty liver disease (NAFLD) a prospective clinicopathological follow-up study, Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, 23/08/2013 to 23/08/2013, Malaysian Society of Gastroenterology and Hepatology (National)
  • Prevalence of NAFLD among Patients in the Outpatient Diabetic Clinic of a Malaysian Tertiary Care Hospital , Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2012, 29/06/2012, Malaysian Society of Gastroenterology and Hepatology (National)
  • POSTER PRESENTER
  • Efficacy & safety of ravidasvir + sofosbuvir in hepatitis C: STORM-C-1 final results, Conference on Retroviruses and Opportunistic Infections, 12/02/2022 to 16/02/2022, International Antiviral Society USA (IAS USA) (International)
  • Concordance between FibroScan and Aspartate aminotransferase-to-Platelet Ratio Index (APRI) using different cut-off values in 301 Asian adults with chronic HCV with no or compensated cirrhosis in Thailand and Malaysia, International Viral Hepatitis Elimination Meeting (IVHEM) 2020, 04/12/2020 to 05/12/2020, Drugs for Neglected Diseases initiative (DNDi) (International)
  • Comparison of attenuation parameter and liver stiffness measurement using fibrotouch vs fibroscan in patients with chronic liver disease , Annual Scientific of MSGH Virtual GUT 2020, 27/11/2020 to 29/11/2020, Malaysian Society of Gastroenterology and Hepatology (International)
  • Clinical and patient-reported outcomes data of non-alcoholic fatty liver disease: longitudinal data from the global NASH registry , The Liver Meeting Digital Experience, 13/11/2020 to 16/11/2020, Americal Association for the Study of Liver Diseases (International)
  • Significant knowledge gap about non-alcoholic fatty liver disease (NAFLD) in real-world practices: a global survey of hepatologists, gastroenterologists, endocrinologists and primary care physicians, The Liver Meeting Digital Experience , 13/11/2020 to 16/11/2020, American Association for the Study of Liver Diseases (AASLD) (International)
  • Comparison of attenuation parameter and liver stiffness measurement using fibrotouch vs fibroscan in patients with chronic liver disease, The Liver Meeting Digital Experience, 13/11/2020 to 16/11/2020, American Association for the Study of Liver Diseases (International)
  • Patient-reported outcomes in patients with chronic Hepatitis C: data from The Global Liver Registry , The Liver Meeting Digital Experience, 13/11/2020 to 16/11/2020, American Association for the Study of Liver Diseases (International)
  • The impact of chronic Hepatitis B on patient-reported outcomes from The Global Liver Registry , The Liver Meeting Digital Experience, 13/11/2020 to 16/11/2020, American Association for the Study of Liver Diseases (International)
  • Association between the components of metabolic syndrome and histological severities in patients with non-alcoholic fatty liver disease , 28th Annual Conference of the Asia Pacific Association for the Study of Liver, 20/02/2019 to 24/02/2019, Asia Pacific Association for the Study of Liver (International)
  • Prescription of statin and treatment targets in non-alcoholic fatty liver disease patients , 28th Annual Conference of the Asia Pacific Association for the Study of Liver, 20/02/2019 to 24/02/2019, Asia Pacific Association for the Study of Liver (International)
  • Impact of Hepatic Steatosis on Patients with Chronic Hepatitis B, 28th Annual Conference of the Asia Pacific Association for the Study of Liver, 20/02/2019 to 24/02/2019, Asia Pacific Association for the Study of Liver (International)
  • Severity of NAFLD across Asian countries and predictors of severe disease, 28th Annual Conference of the Asia Pacific Association for the Study of Liver, 20/02/2019 to 24/02/2019, Asia Pacific Association for the Study of Liver (International)
  • MACK-3 (Combination of hoMa, Ast, CK18): a promising novel biomarker for fibrotic non-alcoholic steatohepatitis , 28th Annual Conference of the Asia Pacific Association for the Study of Liver, 20/02/2019 to 24/02/2019, Asia Pacific Association for the Study of Liver (International)
  • Macroscopic On-site Quality Evaluation (MOSE) of Biopsy Specimens to Improve The Diagnostic Accuracy During EUS-Guided FNA Using a 19G Needle for Solid Lesions: A Prospective Randomized Controlled Study., Digestive Disease Week Scientific Sessions 2018 , 02/06/2018 to 05/06/2018, Digestive Disease Week (International)
  • Safety and efficacy of ravidasvir plus sofosbuvir 12 weeks in non-cirrhotic and 24 weeks in cirrhotic patients with hepatitis C virus genotype 1,2,3,and 6 The STORM-C-1 phase IIIII trial, The International Liver Congress 2018, 11/04/2018 to 15/04/2018, EASL-The Home of Hepatology (International)
  • A non-invasive biomarker of hepatic inflammation based on magnetic resonance imaging. Journal of Hepatology, The International Liver Congress 2018, 11/04/2018 to 15/04/2018, EASL-The Home of Hepatology (International)
  • Comparison of HepaFat-Scan and controlled attenuation parameter for the estimation of hepatic steatosis in patients with non-alcoholic fatty liver disease using histology as the reference standard, The International Liver Congress 2018, 11/04/2018 to 15/04/2018, EASL-The Home of Hepatology (International)
  • A pilot study of empagliflozin for the treatment of non-alcoholic steatohepatitis in patients with type 2 diabetes mellitus, The International Liver Congress 2018, 11/04/2018 to 15/04/2018, EASL-The Home of Hepatology (International)
  • Comparing the BCLC and HKLC Staging System in the Management of Hepatocellular Carcinoma in a Tertiary Center in Malaysia, Annual Scientific Congress Malaysian Society of Gastroenterology and Hepatology, GUT 2017, 11/08/2017 to 13/08/2017, Malaysian Society of Gastroenterology and Hepatology (National)
  • A Substantial Proportion of Patients with Chronic Hepatitis B have a Significant Fibrosis and Concomitant Fatty Liver: Results from a Cross-Sectional Study using Fibroscan at a Major Tertiary Hospital in Malaysia, Annual Scientific Congress Malaysian Society of Gastroenterology and Hepatology, GUT 2017, 11/08/2017 to 13/08/2017, Malaysian Society of Gastroenterology and Hepatology (National)
  • Do the same-cut-off values for controlled attenuation parameter (CAP) apply for both M probe and XL probe of transient elastography [Fibroscan]?, Annual Scientific Congress Malaysian Society of Gastroenterology and Hepatology, GUT 2017, 11/08/2017 to 13/08/2017, Malaysian Society of Gastroenterology and Hepatology (National)
  • Non-alcoholic fatty liver disease - demographic features, risk factors and treatment practices across the Asia Pacific region -GO ASIA initiative, The International Liver Congress 2017, 19/04/2017 to 23/04/2017, European Association for the Study of the Liver (EASL) (International)
  • Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein as a serum biomarker for disease severity in non-alcoholic fatty liver disease, The International Liver Congress 2017, 19/04/2017 to 23/04/2017, European Association for the Study of the Liver (EASL) (International)
  • Serum Aspartate Aminotransferase Levels As A Predictor of Histological Improvement in Patients with Non-Alcoholic Steatohepatitis : Results from A Randomized, Double- Blinded, Placebo- Controlled Study, Asian Pacific Digestive Week APDW 2016: Innovative Approaches To Gastroenterology, 02/11/2016 to 05/11/2016, APDW 2016 Kobe (International)
  • Hepatitis B Virus Infection Among Children of Hepatitis B Surface Antigen Positive Mothers In A Tertiary Hospital In Malaysia, Asian Pacific Digestive Week APDW 2016: Innovative Approaches To Gastroenterology, 02/11/2016 to 05/11/2016, APDW 2016 Kobe (International)
  • Is Silymarin Useful for the Treatment of Non- Alcoholic Fatty Liver Disease?: A Meta Analysis, GUT 2016: Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology, 22/07/2016 to 24/07/2016, Malaysian Society of Gastroenterolgy and Hepatology (MSGH) (National)
  • A Study on Transmission of Hepatitis B Virus Infection Among Children of Hepatitis B Surface Antigen Positive Mothers from A tertiary Hospital in Malaysia, GUT 2016: Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology, 22/07/2016 to 24/07/2016, Malaysian Society of Gastroenterolgy and Hepatology (MSGH) (National)
  • Serum Cathepsin D and Cytokeratin-18 Levels for Lobular Inflammation and Balloning in Adult NAFLD Patients: Non Invalsive Biomarkers in Diagnosis of Non Alcoholic Steatohapetitis (NASH) In Adult patients, GUT 2016: Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology, 22/07/2016 to 24/07/2016, Malaysian Society of Gastroenterolgy and Hepatology (MSGH) (National)
  • Serum Aspartate Aminotransferase Levels As A Predictor of Histological Improvement in Patients with Non-Alcoholic Steatohepatitis : Results from A Randomized, Double- Blinded, Placebo- Controlled Study, Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2016, 22/07/2016 to 24/07/2016, Malaysian Society of Gastroenterolgy and Hepatology (MSGH) (National)
  • A Study of Non-Alcoholic Fatty Liver Disease Using Trasient Elastography and Carotid Intima Media Thickness Using Ultrasonography in a Middle-Aged Malaysian Cohort, GUT 2016: Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology, 22/07/2016 to 24/07/2016, Malaysian Society of Gastroenterolgy and Hepatology (MSGH) (National)
  • An Overview and Practical Management of Non-Alcoholic Fatty Liver Disease, 56TH ANNUAL GENERAL MEETING & ANNUAL SCIENTIFIC CONGRESS, 23/04/2016 to 24/04/2016, PRIVATE MEDICAL PRACTITIONERS'S ASSOCIATION OF SELANGOR AND KUALA LUMPUR (PMPASKL) (National)
  • Silymarin Improves Fibrosis In Non-Alcoholic Steatohepatitis, The International Liver Congress 2016, 13/04/2016 to 17/04/2016, EASL (EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER) (International)
  • Silymarin for the treatment of non-alcoholic steatohepatitis: Interim analysis of a randomized, double-blind, placebo-controlled trial, Asian Pacific Digestive Week 2015, 03/12/2015 to 06/12/2015, Asian Pacific Digestive Week Federation  (International)
  • Is controlled attenuation parameter with the XL probe more accurate than the M probe for estimation of hepatic steatosis in patients with non-alcoholic fatty liver disease?, Asian Pacific Digestive Week 2015, 03/12/2015 to 06/12/2015, Asian Pacific Digestive Week Federation (International)
  • Increasing Obesity and GI diseases in ASIA Gut and Obesity in Asia (GOASIA) consensus statements on obesity and gastrointestinal diseases, Asian Pacific Digestive Week 2015, 03/12/2015 to 06/12/2015, Asian Pacific Digestive Week Federation  (International)
  • Limited utility of plasma M30 in discriminating non- alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers., Asia Pacific Association for the Study of Liver 2015 Meeting, 01/06/2015 (International)
  • A novel 2 step approach combining the nafld fibrosis score and liver stiffness measurement for predicting advanced fibrosis, Asia Pacific Association for the Study of Liver 2015 Meeting, 01/06/2015 (International)
  • Silymarin for the treatment of non-alcoholic steatohepatitis: interim analysis of a randomized, double-blind, placebo-controlled trial., International Liver Conference 2015, 01/06/2015 (International)
  • Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers. , Asia Pacific Digestive Week 2014, 24/11/2014 to 24/11/2014
  • Combination of NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis in non-alcoholic fatty liver disease., Asia Pacific Digestive Week 2014, 24/11/2014 to 24/11/2014
  • Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers, GUT 2014 and ECCO Educational Workshop, 22/08/2014 to 24/08/2014, Malaysian Society of Gastroenterology and Hepatology (National)
  • Controlled Attenuation Parameter for The Detection and Quantification of Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease, GUT 2014 and ECCO Educational Workshop , 22/08/2014 to 24/08/2014, Malaysian Society of Gastroenterology and Hepatology (National)
  • Combination of NAFLD Fibrosis Score and Liver Stiffness Measurement for Predicting Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease, GUT 2014 and ECCO Educational Workshop , 22/08/2014 to 24/08/2014, Malaysian Society of Gastroenterology and Hepatology  (National)
  • Controlled attenuation parameter for the detection and quantification of hepatic steatosis in non-alcoholic fatty liver disease, 23rd Conference of the Asian Pacific Association in the Study of the Liver 2014, 12/03/2014 to 15/03/2014, Asian Pacific Association in the Study of the Liver  (International)
  • Prevalence of NAFLD and Associated Factors in a Young Multi-Racial Malaysian Population, Gastro 2013 Asia Pacific Digestive Week / World Congress of Gastroenterology Shanghai, 23/09/2013, Asia Pacific Digestive Week Federation, Chinese Societies of Digestive Diseases, World Endoscopy Organization, and World Gastroenterology Organization  (International)
  • US-Diagnosed NAFLD Is Not Associated with IHD among Long-Standing Poorly-Controlled Diabetics, Gastro 2013 Asia Pacific Digestive Week / World Congress of Gastroenterology Shanghai, 23/09/2013, Asia Pacific Digestive Week Federation, Chinese Societies of Digestive Diseases, World Endoscopy Organization, and World Gastroenterology Organization  (International)
  • Split Versus Whole-Dose PEG-ELS For Bowel Preparation In Outpatient Colonoscopy, Gastro 2013 Asia Pacific Digestive Week / World Congress of Gastroenterology Shanghai, 22/09/2013, Asia Pacific Digestive Week Federation, Chinese Societies of Digestive Diseases, World Endoscopy Organization, and World Gastroenterology Organization (International)
  • Non-alcoholic fatty liver disease in young adults worrying ethnic differences in a multi-racial Asian population in Malaysia, Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, 23/08/2013 to 25/08/2013, Malaysian Society of Gastroenterology and Hepatology (National)
  • Reduced-volume PEG-ELS plus bisacodyl split-dose is better than same morning whole-dose for morning outpatient colonoscopy: result of an investigator- and endoscopist-blinded, randomized study, Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, 23/08/2013 to 25/08/2013, Malaysian Society of Gastroenterology and Hepatology (National)
  • Low physical activity and high percentage calorie intake from fat, high cholesterol food and high saturated fatty acid food is associated with NAFLD in centrally obese diabetics, Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, 23/08/2013 to 25/08/2013, Malaysian Society of Gastroenterology and Hepatology (National)
  • Ultrasonography-diagnosed non-alcoholic fatty liver disease (NAFLD) is not associated with prevalent ischemic heart disease (IHD) among long-standing poorly controlled diabetics., Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, 23/08/2013 to 25/08/2013, Malaysian Society of Gastroenterology and Hepatology (National)
  • Prevalence of NAFLD among Diabetic Patients in the Outpatient Clinic of a Malaysian Hospital and Associated Factors, Asian Pacific Digestive Week 2012: Achieving Excellence in Gastroenterology & Hepatology, 05/12/2012 to 08/12/2012, Asian Pacific Digestive Week Federation, Asian Pacific Association of Gastroenterology, Asian Pacific Association for the Study of Liver, Asian Pacific Society for Digestive Endoscopy and International Society for Digestive Surgery (International)
  • Clinical and Histological Follow-Up of a Cohort of Patients with NAFLD, Asian Pacific Digestive Week: Achieving Excellence in Gastroenterology & Hepatology, 05/12/2012 to 08/12/2012, Asian Pacific Digestive Week Federation, Asian Pacific Association of Gastroenterology, Asian Pacific Association for the Study of Liver, Asian Pacific Society for Digestive Endoscopy and International Society for Digestive Surgery
  • The Role of Diet and Physical Activity in Non-Alcoholic Fatty Liver Disease (NAFLD) in Diabetic Patients, The 3rd Asian-Pacific Topic Conference: Nutritional Related Disorders and Digestive System, 02/11/2012 to 03/11/2012, Japanese Society of Gastroenterology (JSGE) and Asian Pacific Association of Gastroenterology (APAGE) (International)
  • Clinical and Histological Follow-Up of a Cohort of Patient with Non-Alcoholic Fatty Liver Disease (NAFLD), Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2012, 29/06/2012 to 01/07/2012, Malaysian Society of Gastroenterology and Hepatology (National)
  • Endoluminal Clipping Versus Surgery In The Management Of Iatrogenic Colonic Perforation: A Direct Cost Analysis , Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2012, 29/06/2012 to 01/07/2012, Malaysian Society of Gastroenterology and Hepatology (National)
  • Patient satisfaction of outpatient gastroscopy in University of Malaya Medical Centre Endoscopy Unit , Asia Pacific Digestive Week 2011: Integrating Science and Technology in Clinical Gastroenterology, 01/10/2011 to 04/10/2011, Asia Pacific Digestive Week Federation (International)
  • Iatrogenic colonic perforations during colonoscopy: incidence, management and outcome in a Malaysian tertiary hospital, Asia Pacific Digestive Week 2011: Integrating Science and Technology in Clinical Gastroenterology, 01/10/2011 to 04/10/2011, Asia Pacific Digestive Week Federation (International)
  • Iatrogenic colonic perforations during colonoscopy: incidence, management and outcome in a Malaysian tertiary hospital., Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology - GUT 2011, 01/03/2011 (National)
  • Patient satisfaction of outpatient gastroscopy in University Malaya Medical Centre endoscopy unit., Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology - GUT 2011, 01/03/2011 (National)
  • Risk factors for poor bowel preparation and its impact on technical performance and patient comfort in an Asian population, Asia Pacific Digestive Week 2010: Gastroenterology in Asia Pacific - Excellence in the New Decade, 19/09/2010 to 22/09/2010, Malaysian Society of Gastroenterology and Hepatology (International)
  • Patient satisfaction with various aspects of an outpatient colonoscopy service, Asia Pacific Digestive Week 2010: Gastroenterology in Asia Pacific - Excellence in the New Decade, 19/09/2010 to 22/09/2010, Malaysian Society of Gastroenterology and Hepatology (International)
  • PRESENTER
  • Current Therapies - What Has Promise? What Does Not?, Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology (GUT2018), 13/07/2018 to 15/07/2018, Malaysian Society of Gastroenterology and Hepatology  (International)
  • Outcomes of Biopsy-Proven Non-Alcoholic Fatty Liver Disease (NAFLD) in South East Asian Patients: A Single Tertiary Center Experience, Annual Scientific Congress of the Malaysian Society of Gastroenterology and Hepatology GUT 2017, 11/08/2017 to 13/08/2017, Malaysian Society of Gastroenterology and Hepatology (International)
  • An Asian Multicentre Study On Biopsy-Proven NAFLD Patients-Part of The GO ASIA Initiative, Asian Pacific Digestive Week APDW 2016, 02/11/2016 to 05/11/2016, Asian Pacific Digestive Week APDW 2016 Kobe (International)
  • Serum Aspartate Aminotransferase Levels As A Predictor of Histological Improvement in Patients with Non-Alcoholic Steatohepatitis : Results from A Randomized, Double- Blinded, Placebo- Controlled Study, Asian Pacific Digestive Week APDW 2016: Innovative Approaches To Gastroenterology, 02/11/2016 to 05/11/2016, APDW 2016 Kobe (International)
  • Hepatitis B Virus Infection Among Children of Hepatitis B Surface Antigen Positive Mothers In A Tertiary Hospital In Malaysia, Asian Pacific Digestive Week APDW 2016: Innovative Approaches To Gastroenterology, 02/11/2016 to 05/11/2016, APDW 2016 Kobe (International)
  • New Therapeutic Options for NAFLD, Asian Pacific Digestive Week APDW 2016: Innovative Approaches To Gastroenterology, 02/11/2016 to 05/11/2016, APDW 2016 Kobe (International)
  • A Study on Transmission of Hepatitis B Virus Infection Among Children of Hepatitis B Surface Antigen Positive Mothers from A tertiary Hospital in Malaysia, GUT 2016: Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology, 22/07/2016 to 24/07/2016, Malaysian Society of Gastroenterolgy and Hepatology (MSGH) (National)
  • Serum Aspartate Aminotransferase Levels As A Predictor of Histological Improvement in Patients with Non-Alcoholic Steatohepatitis : Results from A Randomized, Double- Blinded, Placebo- Controlled Study, GUT 2016: Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology, 22/07/2016 to 24/07/2016, Malaysian Society of Gastroenterolgy and Hepatology (MSGH) (National)
  • Silymarin Improves Fibrosis In Non-Alcoholic Steatohepatitis, The International Liver Congress 2016, 13/04/2016 to 17/04/2016, EASL (EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER) (International)
  • Infected Walled-Off Necrosis with Disrupted Main Pancreatic Duct Following Acute Gallstone Pancreatitis, Asian Young Endoscopists Award (AYEA) 2015, 07/09/2015 to 18/09/2015, Korean Society of Gastrointestinal Endoscopy (International)
  • Fat in the liver - get it checked before it's too late!, Wednesday Morning Symposium, 14/08/2013 to 14/08/2013 (Others)
  • A case of autoimmune liver cirrhosis, First Klang Valley GI Updates 2010/2011, 09/01/2011 to 09/01/2011, Malaysian Society of Gastroenterology and Hepatology (National)
  • OTHERS
  • Participant, 20th PGI-AIIMS Current Perspectives in Liver Disease-CPLD 2020 Virtual Conference, 10/10/2020 to 11/10/2020, Department of Hepatology, PGIMER, Chandigarh and Department of Gastroenterology AIIMS, New Delhi (International)
  • Participant, 2nd BEL-G - Bariatric Endoscopy Live Global, 02/10/2020 to 02/10/2020, Gastroentestinal Endoscopy Unit, University of Sao Paulo and Division of gastroenterology, Hepatology and Endoscopy, Harvard Medical School (International)
  • 18th MSGH Oration: Hepatitis E in Asia, Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology (GUT 2018), 13/07/2018 to 15/07/2018, Malaysian Society of Gastroenterology and Hepatology (International)
  • NASH and HCV, Singapore Hepatology Conference 2018, 08/06/2018 to 09/06/2018, Singapore Hepatitis Conference Pte Ltd (International)
  • Participant, Asia-Pacific Digestive Week (APDW) 2017, 24/09/2017 to 26/09/2017, Asia-Pacific Digestive Week (APDW) Federation (International)
  • Participant, Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology, GUT 2017, 11/08/2017 to 13/08/2017, Malaysian Society of Gastroenterology and Hepatology (National)
  • Early Morning HBV Workshop 3 (half the participants): Case discussion- management of difficult to treat cases NASH & HCV., Singapore Hepatology Conference 2017, 02/06/2017 to 03/06/2017, Singapore Hepatitis Conference Pte Ltd (International)
  • Participant, Calibration Workshop: Masters of Medicine (Internal Medicine), 07/05/2017 to 07/05/2017, Faculty of Medicine and Health Sciences, University Putra Malaysia (UPM) (National)
  • Participant, The International Liver Congress 2017, 19/04/2017 to 23/04/2017, EASL, European Association for the Study of the Liver (International)
  • Participant, Flexible Endoscopic Surgery course, 17/03/2017 to 18/03/2017, Flexible Endoscopic Surgery & Bariatric Endoscopy  (International)
  • Participant, 2017 OverStitch Advanced Suturing Course , 16/03/2017 to 16/03/2017, Flexible Endoscopic Surgery & Bariatric Endoscopy (International)
  • Participant, The 2nd Asan Medical Center EUS-guided Radiofrequency Ablation Training Program, 06/01/2017 to 07/01/2017, ASAN Medical Center and TaeWoong Medical (International)
  • Participant, The 25th Conference of the Asia Pacific Association for the Study of the Liver, 20/02/2016 to 24/02/2016, The Asia Pacific Association for the Study of the Liver (International)
  • Participant, Postgraduate Course, 14/11/2015, American Association for The Study Of Liver Diseases (AASLD) (International)
  • Participant, The Liver Meeting, 13/11/2015 to 17/11/2015, American Association for The Study Of Liver Diseases (AASLD) (International)
  • Participant, Stanford Preceptorship , 10/11/2015 to 11/11/2015, School of Medicine, Stanford University (International)
  • Participant, Asian EUS Congress 2015, 11/09/2015 to 12/09/2015, Asian EUS Group (International)
  • Participant, Asian Young Endoscopists Award (AYEA) 2015, 07/09/2015 to 18/09/2015, Korean Society of Gastrointestinal Endoscopy (International)
  • Participant, Hepato Metabolic GP Workshop, 05/09/2015 to 06/09/2015, MEDA Rottapharm Madaus (National)
  • Participant, Workshop on Developing A Protocol For Cochrane Systematic Review , 24/08/2015 to 27/08/2015, Julius Centre University of Malaya (University)
  • Participant, GUT 2015 Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology, 21/08/2015 to 23/08/2015, Malaysian Society of Gastroenterology and Hepatology  (National)
  • Moderator, GUT 2015 Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology, 21/08/2015 to 23/08/2015, Malaysian Society of Gastroenterology and Hepatology (National)
  • Participant, Train the Trainer, 20/08/2015 to 21/08/2015, Asian EUS Group (International)
  • Visiting Fellow, Endoscopic Ultrasonography, Asian Institute of Gastroenterology, Hyderabad, 04/05/2015 to 08/05/2015
  • Participant, Endoscopy 2015 , 17/04/2015 to 19/04/2015, University of Malaya & Malaysian Society of Gastroenterology and Hepatology  (International)
  • Moderator , Endoscopy 2015, 17/04/2015 to 19/04/2015, University of Malaya & Malaysian Society of Gastroenterology and Hepatology (International)
  • Participant, Asian Pacific Digestive Week 2014, 22/11/2014 to 25/11/2014, Asian Pacific Digestive Week Federation (International)
  • Participant, Postgraduate Course, 22/11/2014, Asian Pacific Digestive Week Federation  (International)
  • Assistant Course Director, 2014 Advanced EUS Workshop, 13/10/2014, University of Malaya Medical Centre (National)
  • Participant, SGI 2014 the Society of Gastrointestinal Intervention , 03/10/2014 to 04/10/2014, SGI 2014 the Society of Gastrointestinal Intervention (International)
  • Participant, EUS2014 19th International Symposium On Endoscopic Ultrasonography, 18/09/2014 to 20/09/2014, EUS2014 19th International Symposium On Endoscopic Ultrasonography (International)
  • Participant, GUT 2014 and ECCO Educational Workshop , 22/08/2014 to 24/08/2014, Malaysian Society of Gastroenterology and Hepatology (National)
  • Participant, The 5th Asia-Pacific Primary Liver Cancer Expert Meeting, 11/07/2014 to 13/07/2014, APPLE 2014 (International)
  • Asian EUS Group Annual Trainers Retreat 2014, Asian EUS Group Annual Trainers Retreat 2014, 21/06/2014 to 22/06/2014, GIHEP Singapore 2014 (International)
  • The New Era in Clinical Management of Liver Fibrosis, 2nd Asia Liver Fibrosis Forum, 24/05/2014, CFHPC (International)
  • Faculty, Asian EUS Group Workshop, 30/03/2014, University of Malaya (National)
  • Participant, Endoscopy 2014: The Best Tips in Therapeutic Endoscopy, 28/03/2014 to 30/04/2014, University of Malaya
  • Participant, MSGH Update in Gastroenterology and Hepatology, 15/02/2014, Malaysian Society of Gastroenterology and Hepatology (National)
  • Participant, Gastroenterology Workshop 2013, 24/10/2013 to 25/10/2013
  • Techniques of Addressing Nonconformance Reports & Root Cause Analysis, Techniques of Addressing Nonconformance Reports & Root Cause Analysis Training, 11/09/2013 to 12/09/2013
  • Delegate, APASL Liver Week , 06/06/2013 to 10/06/2013, The Gastroenterological Society of Singapore and The Asian Pacific Association for the Study of the Liver  (International)
  • Delegate, The International Liver Congress 2013, 24/04/2013 to 28/04/2013, The European Association for the Study of the Liver (International)
  • Participant, Asian EUS Group Workshop 2013, 14/04/2013, University of Malaya and Malaysian Society of Gastroenterology and Hepatology (National)
  • Participant, The 2nd Mumbai Interventional EUS Course, 30/03/2013 to 31/03/2013, The Association of Interventional GI Endoscopy of India, The Baldota Institute of Digestive Sciences and The Asian EUS Group (International)